Developing a sacrificial protective group to geliver the 1,2 cis glycoside by Grey, LG
1 
 
 
 
 
 
 
Developing a Sacrificial Protective 
Group to Deliver the 1,2 cis 
Glycoside 
 
 
 
 
 
Laurence G. Grey 
 
A Thesis Submitted in Partial Fulfilment of the 
Requirements of the Degree of Doctor of Philosophy  
For Nottingham Trent University. 
 
 
October 2016 
 
 
 
 
School of Science and Technology 
Nottingham Trent University 
Clifton Lane 
Nottingham 
NG11 8NS 
Dedication   
 2 
Dedication 
 
 I would like to dedicate this thesis to grandfather, Cpt. George Douglas Willis. The 
greatest man I have ever known.  
  
Abstract   
 3 
Abstract 
 
 The purpose of this study was to investigate whether the stereochemistry of a newly 
formed glycoside bond could be controlled through the novel use of an appropriately 
functionalised sacrificial neighbouring protecting group. This methodology would complement 
existing chemistries but with the added advantage that it would not require a two-step 
intramolecular delivery system, but instead involve a single-step synthesis of a cis glycoside 
bond from a neighbouring acetal or ketal group, armed with the same leaving group as the 
anomeric position. 
 
 
Scheme 1. Proposed approach to a novel neighbouring group direction. 
 
 The first goal of the study was the synthesis of a 3,4,6-tri-O-protected, 2-O-unprotected 
glycoside donor to which the desired neighbouring group system could be attached. We 
investigated multiple synthetic routes and approaches to achieve our target donor, which 
ultimately resulted in an efficient four-step synthesis of ethyl, 3,4,6-tri-O-benzyl 
thioglucopyranoside, and its n-pentenyl ether analogue. 
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Scheme 2. Summary of Section 2.1. 
 
 We found that attaching a mixed thioacetal, thio ketal acetal, or a ketal to our donor 
proved to be difficult. Acetals are renowned for their instability, especially glycosidic acetals, 
and this was confirmed in this study.  
 
 Thioacetal derivatives were also explored, but were unfortunately found to be too 
unstable for further study. We found that n-pentenyl ethers were considerably more stable. 
After multiple attempts, a para-methoxy benzyl mixed acetal was found to be very unstable.  
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Scheme 3. Summary of Section 2.2. 
 
 Finally, we identified that an isopropylidene mixed ketal, which is expected to be more 
stable, would allow us to test our theory. Unfortunately, though, within the time constraints of 
the project there was not enough time to carry out this final investigation. 
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1.1. Glycosides 
 
 Carbohydrates play a significant role in biological processes, as well as being one of 
the most abundant group of biomolecules on the planet. The need for an efficient synthesis of 
oligosaccharides (Branched or unbranched polysaccharides.) is still on the front of 
carbohydrate research. Oligosaccharides are found in biology in numerous functions, 
particularly as protein or lipid bound glycocalyxes protruding out of the membrane of cells. 
These protruding glycosides function in intercellular interactions, allowing cells to recognise 
the cell next to it amongst other functions. They are also present on the membranes of bacteria 
and some viruses for similar functions. These oligosaccharides can be extremely complex in 
their construct due to the large amount of regio and steric possibilities that the glycosides can 
assume. They are present on the surface of invading foreign bodies (either bacterial or viral) 
and can be targeted by the hosts immune system as antigens. Therefore, the glycans presented 
on the outer surface membrane of the bacterium (or virus) are notable targets for developing 
vaccines. Some of the carbohydrates are attached to phospholipids, which merge into the ‘fluid 
mosaic’ of the cells membrane. Figure 1 presents a diagram of the fluid mosaic, outlining the 
presence of glycophospholipids (1). 
 
 
Figure 1. The fluid mosaic model of a cell membrane (1). 
 
An example of an extracellular oligosaccharide is the Forssman antigen, Figure 2, 
which is a cancer specific antigen that has been used as a vaccine for particular types of 
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cancers. The glycocalyx is found on the surface membrane of Forssman positive animal cells. 
Forssman negative animals, like humans, cannot create the terminal, second, α-N-acetyl-D-
galactosamine (αGalNAc), instead only present the single αGalNAc (2). The Forssman 
antigen is presented on the cell surface as a possible immune response target (3), when a 
mutation has taken place, for example mutations that some human breast cells undergo in their 
transformation into cancer cells. 
 
 
Figure 2. The Forssman Antigen 
 
 The Forssman antigen, 1, belongs to a class of glycolipids called sphingoglycolipids. 
A sphingosine is a 4,5-unsaturated lipid with a functionalised 2-amino-1,3-diol moiety. In this 
case, the primary alcohol is phosphorylated with a zwitterionic phosphocholine group, 
allowing it to merge into the lipid bilayer. The glycocalyx is subsequently attached to the 
secondary amine through a fatty acid residue, thus inducing the protrudance of the Forssman 
antigen outward from the cell membrane.  
 
Whilst the glycolipid has been named the Forssman antigen due to its presence on 
Forssman positive animal cells it is not an as antigen. It only becomes an antigen on triggering 
an immune response to a foreign body. Studies on the Forssman antigens on Forssman positive 
cells using the antibody have suggested that the function of the Forssman antigen is in 
intercellular adhesion, but its full function is not yet known (4). 
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Unfortunately, all cells have a large amount of different oligosaccharides thus isolating 
them, in quantities large enough to utilise as vaccines, becomes a complex and high cost task. 
Hence efficient, controlled oligosaccharide synthesis is a popular challenge to the organic 
chemist, in particular addressing cis-O-glycoside synthesis. This is because the factors which 
contribute the product of O-glycosylation are easily manipulated to the formation of trans-O-
glycosides, more about this will be covered in the latter part of the section. 
 
A large amount of work has been done in the field of carbohydrate synthesis. In the 
19th century, Emil Fischer pioneered synthetic carbohydrate chemistry by developing the 
glycosylation of methanol with glucose with an acid catalyst in what became known as the 
Fischer glycosylation (Scheme 4) (5). The glycoside bond is the acetal formed from the 1st 
position of the carbohydrate ring, also known as the anomer. 
 
 
Scheme 4. Fischer’s glycosylation method. 
 
Fischer’s reaction was acid catalysed, but over the years since his discovery various 
acids and Lewis acids were implemented in similar reactions by other researchers. Vincent 
Ferrières discovered that using different Lewis acids can change the outcome of the reaction 
regarding the glycosides furano or pyrano forms (6). The Fischer-like reactions are 
unprotected glycosylation reactions with alcoholic solvents as the acceptor, for coupling two 
glycosides, the inefficiencies would lie with self-glycosylation products. To overcome this 
issue, along with the need to use vast excesses of the glycoside acceptor, Koichi Fukase used 
trimethyl silyl chloride to catalyse the glycosylation (Scheme 5) (7). 
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Scheme 5. Mechanism of Fukases modified Fischer glycosylation (7). 
 
The glycosylation of methanol with glucose in Scheme 5 uses trimethyl silyl chloride, 
(TMSCl), and water to generate trimethyl methoxy silane, 3, and MeOH2
+. The MeOH2
+ 
generates the oxocarbenium ion, 4, and trimethyl methoxy silane acts as a methoxide ion 
which attacks the oxocarbenium ion.  
 
Fischer’s glycosylation method was the first account of chemical glycosylation and 
serves as a basis for the majority of glycosylation chemistry that followed. When glycosylating 
two glycosides to synthesise a disaccharide, the use of protecting groups to prevent self-
glycosylation is required and a general overview is shown in Scheme 6. 
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Scheme 6. General glycosylation reaction. 
 
The reaction involves various parts: a protected glycoside donor 5, the anomers leaving 
group X, the activating agent A and the glycoside acceptor 7. This reaction is an SN1 style 
glycosylation reaction and the rate-determining step of the reaction is the formation of the 
oxocarbenium ion 6, on activation of the leaving group. Increasing the nucleophilicity of the 
leaving group directly increases the rate of glycosylation (8). Conversely, stabilising the 
oxocarbenium ion 6, will slow the reaction rate by introducing a more stable intermediate. The 
acceptor controls the regio selectivity of the glycoside bond formed through protecting groups. 
The stereochemistry is controlled by numerous factors and is defined as the ratio of 8:9, or α:β 
(9). Simply alkylating the anomeric hydroxide is not a glycosylation reaction, although the 
product can be a glycoside. 
 
 In Fukases glycosylation of methanol, Scheme 5, the glucose is acting as the donor. 
The anomeric hydroxide acts as the leaving group. The TMSCl in the presence of water and 
methanol generates the MeOH2
+, which activates the anomeric hydroxide and removes it as a 
cationic MeOH2
+. The TMSOMe acts as a glycoside acceptor. Since they were only activating 
the anomeric hydroxide and reacting the subsequent oxocarbenium ion with a reactive 
TMSOMe in methanol, there was no need for protecting groups with this method. Self-
glycosylation of the glucose would have been a very minor product not only because of the 
sheer volume of methanol present as it was the solvent, but because the TMSCl works to 
activate the methanol. The stereochemistry of the anomeric methoxy group is controlled 
predominantly by the anomeric effect (Figure 3) 
 
 The anomeric effect occurs when a lone pair on the cyclic oxygen is peri-planar to the 
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anomeric anti-bonding orbital of the anomeric C-O bond, and can donate electron density. 
This effect is strongest when the receiving anomeric carbon’s non-cyclic bonding orbital is 
losing electron density to an electron withdrawing group (10), such as halides, sulphides, 
oxides. This is why, in methanol, the α anomer is the favoured product of the glycosylation of 
methanol, and what little of the β anomer is negligible. 
 
 
Figure 3. The anomeric effect. 
 
Hexopyranoses and their subsequent pyranosides are most stable in their 4C1 
conformation. C relates to the chair conformer. C1 relates to the C1 anomer at the lowest 
position and 4C being the highest cyclic C4 carbon when looking at the chair with the O – C5 
and the C2 –C3 bond in the plane. The glycoside bond is written as either α or β, but whether 
it is cis or trans is dependent upon the C2 substituent. For example, when the sugar is in its 
4C1 conformation, mannose whose C2 substituent is axial, making its β (equatorial) anomer 
cis. Whereas the C2 substituent of glucoses is equatorial meaning the α anomer is the cis. 
 
 
Figure 4. Conformational terms. 
 
When the 2,3,4 and 6-hydroxides are protected, their solubility in water is drastically 
reduced and thus, less polar, organic solvents are required to dissolve them. The epimerisation 
of the anomeric centre in water affects the α:β ratio as when solvated, with water, steric 
influences become a major factor in the anomerisation, increasing the amount of the β product. 
In polar organic solvents the anomeric effect prevails in determining the α:β ratio at 
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equilibrium Figure 5 (11). 
 
Figure 5. Anomeric v’s steric effects. 
 
 According to the anomeric effect, a sterically less favoured axial α anomer is the most 
stable configuration in organic solvents. In an aqueous environment the equatorial β anomer 
becomes more stable as a configuration of D-glucose. This is because the axial components 
have increased axial – axial and axial – equatorial interactions from becoming solvated. To 
minimise this, the β anomer becomes the favoured anomer (11). 
 
Anomeric changes can occur through anomerisation. This can be from mutarotation, 
or from substitution when the leaving group is exchanged either in SN1 or SN2 type reactions. 
The anomeric carbon is the C1-O carbon and can have the functionality of a hemiacetal, an 
acetal or a carbonyl. Depending on the nature of the anomeric carbon, carbohydrates can be 
defined as either a ketose or an aldose, of which examples of these can be found in the 
monosaccharides that make up the disaccharide sucrose, 10, which are fructose and glucose 
respectively Scheme 7. 
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Scheme 7. The components of sucrose. 
 
 
Scheme 8. Mutarotation of a hemiacetal. 
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 Mutarotation occurs when the anomeric hydroxide and cyclic hemiacetal group 
exchange a proton via the open chain form of the sugar Scheme 5. This does not occur when 
the anomer is an acetal. 
 
 Considering the reactivity of protected glycoside donors in organic solvents, if the 
anomeric carbon’s leaving group is activated then the electron donating ability of the cyclic 
oxygen will displace the leaving group, creating the reactive oxocarbenium ion, which can 
exist as 4 conformers (Scheme 9) (12) (13). 
 
 
 
Scheme 9. Conformational analysis of the oxocarbenium ion. 
 
 The example shown in Scheme 9 is that of mannose, whose C2 hydroxide is in an axial 
position. Once ionised to the oxocarbenium ion, its conformers resemble the conformers of 
cyclohexene and consist of two unstable boat conformers, 11 and 14, and two considerably 
more stable twisted chair conformers. Analysing the pseudo syn-axial interactions, we can 
calculate that 13 is the more stable of the two. Thus the approach of a nucleophile is most 
likely to happen from the down position of 13, resulting in the formation of glycoside 16 as 
the most favoured product (12) (13). 
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Scheme 10. Favoured approach of the nucleophile to the oxocarbenium ion. 
 
 Although the product of the least hindered approach of conformer 12 would result in 
an equatorial α product, this outcome lacks any anomeric effect and the syn-axial interactions 
of 15 are considerably larger than any of the corresponding interactions of conformer 16 
(Scheme 10). The 4C1 is the most stable conformation. 
 
 In oligosaccharide synthesis and complex carbohydrate synthesis, a protecting group 
strategy needs to be incorporated. The glycoside acceptors and donors need to be protected, 
not only to prevent self-glycosylation products forming, but to ensure that there is only one 
regioselected glycoside bond formed, as in the synthesis of isomaltose in Scheme 11. 
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Scheme 11. Synthesis of isomaltose.  
a)1-penten-4-ol, HCl, overnight, r.t., b) BnBr, NaH, DMF, 8hrs, 0oc, c) MeOH, HCl, overnight, 
r.t., d) TBDMSCl, Et3N, DMAP, overnight, 36
oc, e) BnBr, NaH, DMF, 8hrs, 0oc, f) AcOH, 
THF, overnight, r.t., g) NIS, DCM, overnight, r.t., h) TfOH, AcOH, overnight, r.t., i) Pd, H2, 
Tol, overnight, r.t. (14) 
 
 Isomaltose 20 is the disaccharide of two glucose monomers connected by an α 1-6 
glycoside bond. Being a disaccharide, it has two anomeric carbons. A hemiacetal which will 
undergo mutarotation, and an acetal linking the glucosides together (the glycoside bond). In 
order to create this chemically, treatment of the two glucose monomers separately is required. 
In nature the glycoside bond is stereoselectively and regioselectively controlled by the 
enzyme, which acts not only to activate the leaving group and protect the glucosides 
accordingly, but also direct the approach of the acceptor to the anomer. Natural, or 
biosynthesised, isomaltose is 100% α (15), whereas the chemical route shown in scheme 11 
generates 20 as approximately 1.6:1 α:β (14).  
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 In generating the glucoside acceptor, the use of Fischer’s glycosylation methodology 
and protection of the anomeric hydroxide is achieved easily. Taking advantage of the primary 
(C6) hydroxide also being the target acceptor, the use of steric hindrance to temporarily protect 
just the primary alcohol with a tert-butyl dimethyl silyl (TBDMS) ether allows us to alkylate 
the C2, 3 and 4 alcohol groups with benzyl ether groups and finally remove the TBDMS, to 
provide the methyl 2,3,4 tri-O-benzyl α-D-glucopyranoside acceptor 18. More detail into the 
glycoside donor and leaving group will be covered in the latter part of this introduction. 
 
 Regarding the Forssman antigen, Figure 2, 1 and its synthesis. Feng and Ogawa (2011 
and 1989, Scheme 12 and Scheme 13) achieved the total synthesis of the Forssman antigen. 
Both syntheses were convergent 2+3 approaches, although both of their syntheses were 
successful, there were still issues which could be resolved. Specifically, the stereoselectivity 
of the glycoside bonds formed and multiple de-protection steps (3) (16). 
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Scheme 12. Fengs’ retro synthesis of the Forssman antigen (2011). 
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Scheme 13. Ogawa’s retro synthesis of the Forssman antigen (1989). 
  
 Both the syntheses are convergent 2+3 routes, because of how they synthesised the 1-
3 α-aminogalacto disaccharide, 24 and 29, (α-GalNac-GalNac) and galacto-lactoside 
trisaccharide, 25 and 30, separately, then converged them into the pentasaccharide. Without 
going into much detail about the syntheses, it’s easy to see how one exceeded the other in 
terms of the overall efficiency of the synthesis. Excluding the initial protection of the α-
GalNac-GalNac galactoside monomers but including the synthesis of the protected lactose 
molecules, 23 and 27, Ogawa’s synthesis involved 27 steps. This is because of the number of 
protection group manipulations that were required. Not only did this increase the time and cost 
of the synthesis, but drastically lowered the yield. Whereas Fengs’ approach required minimal 
protecting group manipulations and only involved 13 steps. The other main difference is the 
anchor that they chose for the glycoside to be attached to, Ogawa linked his to a ceramide 
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residue, whereas Feng linked his to an aminohexane group. But taking this into account, it 
only added an extra 3 steps into Ogawa’s synthesis. Not only was work put into reducing the 
number of steps in the synthesis, but also increasing the stereoselectivity of the glycoside 
bonds formed. For example, Ogawa used more classical anomeric bromide as the leaving 
group for the synthesis of 28, which gave an anomeric mixture of 5:1 α:β. Whereas Feng found 
that using an azide at the C2 position of the galactose and a trichloroacetimidate leaving group 
he achieved the α-GalNAc-GalNAc as higher ratio, but only took the alpha anomer off the 
column. (3) (16). Both of these approaches suffered drastically at the lack of stereoselectivity 
within the glycoside bonds formed. Ogawa and Feng had to separate the anomers of 28 and 
24 (respectively) on column chromatography. Not only are the reactions relatively low 
yielding in the first place, but when they separated the anomers, the single anomer yield was 
lowered even further. Ogawa and Fengs’ syntheses of the Forssman antigen are good examples 
of how far carbohydrate research has come in 22 years.  
 Therefore, controlling the anomeric stereooutcome of a glycoside bond forming step 
has become a notable challenge for the carbohydrate chemist. Choosing the correct leaving 
group for the glycoside donor is an important factor in the challenge, depending on the 
approach to stereocontrol being utilised. The following sections 1.1.1. – 1.1.4. are on the 
common leaving groups in glycoside synthesis. 
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1.1.1. Anomeric Halides 
 
 Anomeric halides were amongst the first leaving groups to be implemented in 
carbohydrate synthesis; due to the electronegativity of an anomeric halide, how good they are 
as leaving groups and because their synthesis is relatively straightforward. Anomeric halides 
are typically synthesised from the corresponding glycosyl O-acetate and a protic acid (9) 
(Scheme 14).  
 
 
Scheme 14. Typical glycosyl halide synthesis. 
 
 Unfortunately, using a strong acid to synthesise the anomeric halide has limitations 
regarding the stability and versatility of the other constituents on the carbohydrate. Around the 
turn of the century, Koenigs-Knorr developed a method as an example of activating the halide 
leaving group for carbohydrate synthesis (Scheme 15). 
 
 
Scheme 15. The Koenigs-Knorr glycosylation. (17). 
 
 Similar to the Fischer glycosylation (Scheme 4), the Koenigs-Knorr uses methanol as 
the acceptor as well as the solvent. The method uses mild activating conditions, and also allows 
for the use of non-alcoholic solvents. Thus, presenting an acceptor hydroxide that isn’t the 
solvent makes the Koenigs-Knorr method particularly notable. The Koenigs-Knorr method 
can be modified and performed with mercury(II) bromide as the promoter which is referred to 
as the Helferich method (Scheme 16) (17). 
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Scheme 16. The Helferich method. (9) 
 
 Anomeric chlorides, bromides and iodides were considered to be relatively unstable 
and too reactive to implement into the glycoside coupling reactions. Rather their uses are 
primarily found in the preparation of other glycoside donors. An attractive property of 
anomeric halides is their ability to undergo SN
2 type reactions, inverting the stereochemistry 
of the halide, meaning the subsequent donor formed would have the opposite anomeric 
stereochemistry (9)(p66).  
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1.1.1.1. Glycosyl Chlorides  
 
 Glycosyl chlorides can be synthesised solely as the β anomer from the corresponding 
per-O-acylated glycoside. The following example of this in Scheme 17, takes advantage of an 
effect known as the nitrile effect with acetonitrile as the solvent, which will be discussed in 
more detail in Section 1.2. 
 
 
Scheme 17. Selective synthesis of β-2,3,4,6-tetra acetyl glucopyranosyl chloride. (18) 
 
  This method uses the Lewis acid boron trifluoride etherate (BF3˖OEt2) to activate the 
anomeric acetate and produce the oxocarbenium ion 32, which the chloride ion subsequently 
attacks from the β direction to give the β chloride in over 90% yield (18). Once the β glycoside 
chloride has been obtained, it can be substituted via a SN2 style mechanism to afford an 
anomerically pure α glycoside donor. A good example of this is in the synthesis of α 
thioglycosides, Scheme 18. 
1. Introduction   
 36 
 
Scheme 18. Thioglycosides from the corresponding chloride. (19) 
 
 Advantage of this was taken by Alexei Demchenko, in his exploration into the super 
arming of glycoside donors, as anomerically pure α thioglycosides were a requirement for 
their approach (20).  
 
 The glycosyl chloride can be activated in glycosylation reactions, typically with 
mercury or silver triflates. In Ogawa’s synthesis of the Forssmann antigen from section 1.1., 
in Scheme 13, mentioned earlier, he used a galactosyl chloride, 26, in the synthesis of the α-
galacto-lactoside trisaccharide, 30. He used silver triflate to activate the chloride then coupled 
it with the appropriately protected lactoside. He then had to separate the anomers, and 
manipulate the trisaccharide protecting groups accordingly (Scheme 19) (21). 
 
 
Scheme 19. Ogawa’s use of a glycosyl chloride. (21) 
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1.1.1.2. Glycosyl Bromides 
 
 Glycoside bromides, unlike the chlorides, are easily synthesized as their α anomers as 
shown with Montero’s bismuth - TMSBr bromination of mono, di and trisaccharides from the 
per-O-acylated pyranose (Scheme 20). 
 
 
Scheme 20. Montero’s bromination. (22) 
 
 An attractive feature of Montero’s bromination, is that not only that the product formed 
with α selectivity, but the use of TMSBr with bismuth tribromide as a mild brominating agent. 
The mild conditions allow the bromination of the terminal anomer of polysaccharides, without 
effecting the other glycoside bonds, or other substituents on the molecule (22). Montero gives 
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no explanation as to why the product is α selective, but we can stipulate that the bismuth tri 
Bromide acts to induce in situ anomerisation, and eventually the anomeric effect takes 
precedence over the steric effects with its neighbouring group participant. The glycosyl 
bromides can be activated to the corresponding oxocarbenium ion under similar conditions to 
that of the chloride counterpart, with silver or mercury triflate (23).  
 
A property of the bromide that the corresponding chlorides or fluorides lack is the ability 
of the bromide to undergo in situ anomerisation with a catalytic amount of tetra-n-butyl 
ammonium bromide salt (Scheme 21). 
 
 
Scheme 21. Anomerisation of 2,3,4,6-tetra-acetyl glucosyl bromide. 
 
 This reaction of acetylated glycosyl bromides with tetra-n-butyl ammonium bromide 
can be used to synthesise an ortho-ester (Scheme 22). 
 
 
Scheme 22. Synthesis of ortho esters. (9)(p381) 
 
 The acetylated glycosyl bromide undergoes anomerisation in dry conditions in the 
presence of an alcohol and lutidine. The β anomer will be displaced by the neighbouring acetate 
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as the carbonyl gets attacked by the alcohol, thus forming the ortho ester. Removing the β 
anomer from the equilibrium by forming ortho ester 33, drives the equilibrium to the right, thus 
pushing the reaction to completion (24).  
 
 Acetylated glycosyl bromides can also undergo elimination reactions in the synthesis of 
glycals. This can either be a reductive or an oxidative elimination reaction, meaning the 
glycoside can either have the bromide and the neighbouring hydrogen eliminated, or it can have 
the bromide and the neighbouring oxide moiety eliminated (Scheme 23). 
 
 
Scheme 23. Reduction of 2,3,4,6-tetra-acetyl bromoglucopyranoside. 
 
 Emil Fischer first reduced 2,3,4,6-tetra-acetyl bromoglucopyranoside into its 1-2 
unsaturate, and named it a ‘glucal’. His reaction was a zinc catalysed reductive elimination of 
both the bromide and the neighbouring acetate (25).  
 
 Anomeric bromides still have a strong presence in oligosaccharide synthesis. In 2015, 
Thomas Ziegler reported the synthesis of phthalonitriles bridging two β glucoside residues. 
Their synthesis took advantage of the ability of the α-bromoglucosides to undergo an SN2 
reaction in adding 3,6-dihydroxyphthalonitrile stereoselectively (Scheme 24). 
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Scheme 24. Thomas Ziegler’s 3,6-di-β-D-glucopyranosyl phthalonitrile. (26) 
 
 It was decided to use the α bromoglucopyranoside 2,3,4,6-tetra-acetate not only because 
of the β selective product, but deacylation of the product afforded the bridged glycoside in a 
high yield with no partial deprotection products being observed (26).  
 
1.1.1.3. Glycosyl Iodides 
 
Glycosyl iodides have been extensively studied over the years since Fischer first 
prepared tetra-O-acetyl iodo glucosides from the per-O-acetyl glucoside using HI in AcOH in 
1910 (27). Since this report Bernd Meyer found that it is possible to synthesis the per-O-acetyl 
iodide from the per-O-acetate using just iodine in trimethylsilyl iodide (TMSI) (28). This is a 
useful reaction for in situ generation of the iodide for direct use as an intermediate. 
  
Glycosyl iodides share similar properties to their bromide counterpart regarding their 
ability to undergo SN2 reactions and anomerisation with the corresponding tetra-n-
butylammonium halide. Glycosyl bromides can be activated by silver triflate in the SN1 style 
glycosylation reaction, whereas glycosyl iodides can be activated with cheaper and milder n-
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iodosuccinimide (NIS) or I2, Scheme 25, which creates a much cleaner glycosylation reaction 
possibility (Scheme 25) (9)(p75). 
 
 
Scheme 25. Activating anomerisation of glycosyliodides (9)(p75). 
 
 Iodides differ from the corresponding chloride and bromide in their SN
2 substitution 
reaction in how they are able to substitute with weaker nucleophiles, such as strained cyclic 
ethers and sulphides. The example shown in Scheme 26 is Gervay-Hague’s synthesis of 
functionalised anomeric alkyl chains, and is achieved from in situ formation of the glycosyl 
iodide with TMS-I from the corresponding glycosyl acetate, and then addition of the cyclic 
sulphide, or ether, with MgO (The MgO acts to trap the TMS as its acetate preventing 
interference in the reaction.). The iodide anion then attacks the activated ring to open it forming 
the corresponding open chain anomeric ether, or sulphide, with a terminal iodide (Scheme 26) 
(29). 
 
 
Scheme 26. Anomeric substitution of iodide with a cyclic ether or sulphide (29). 
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1.1.1.4. Glycosyl Fluorides 
 
 Although anomeric iodides, chlorides and bromides have been extensively used in 
carbohydrate research, it wasn’t until the mid-1980s that the reactions of anomeric fluorides 
where fully explored, subsequently proving the fluoride to be the most versatile of the anomeric 
halides. Because of this, anomeric fluorides can be advantageous to an oligosaccharide 
synthesis and multiple routes to synthesising anomeric fluorides have been developed (Scheme 
27). 
 
 
Scheme 27. Synthesis of anomeric fluorides. 
 
 I) Is the traditional method from the per-O-acylated glycosides, similar to Scheme 11 
(30).  
 II) The fluorination of hemiacetals has been extensively studied, in Scheme 27 a select 
few have been listed. It is assumed that the mechanism proceeds through the oxocarbenium ion 
as highlighted in Scheme 28 (9). 
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Scheme 28. Fluorination of a hemiacetal. 
  
 The fluorinating agent by-product will leave either as the corresponding ketone, or 
alcohol depending on the fluorinating agent. For example, 36 will leave as the sulphonic acid, 
whereas selectfluor, 37, when used with stoichiometric amounts of dimethyl sulphide, generates 
an in-situ fluorodimethylsulfonium ion which acts to fluorinate the anomer and leave as the 
corresponding sulphoxide. The counter ion for cationic fluorinating agents is usually 
tetrafluoroborate or tosylate. Specifically, 2-fluoro-1-methylpyridin-1-ium, 36, is used as its 
tosylate, whereas 37 uses two tetrafluoroborate counter ions (31) (32) (33) (34) (35) (36).  
 
 III) Glycosyl fluorides can be synthesised from thioglycosides. This is advantageous 
when fluorinating glycosides with diverse protecting groups, or polysaccharides without 
fluorinating the other constituents on the carbohydrate. The reagent used is a pyridine-
iodinepentafluoride-hydrofluoric salt (IF5-Py-HF), which is air stable at room temperature 
without an inert atmosphere. Making this reaction a notable anomeric conversion. IF5-Py-HF is 
believed to fluorinate via the SN1 mechanism, this is because the reaction produces a mixture 
of anomers from an anomeric pure reactant. It has also been used to fluorinate, non glycosidic, 
alkyl or aryl sulphides (37) (38).  
 
 IV) The conversion of other glycosyl halides into the corresponding fluoride, is another 
method to synthesise glycosyl fluorides. The synthesis can be stereocontrolled depending on 
the reagent(s) used, the use of silver fluoride in acetonitrile achieves the β anomer, subsequent 
treatment with boron trifluoride diethyl etherate can generate the α anomer (39). 
 
 V and VI) The synthesis of glycosylfluorides from glycals is possible, which also 
controls the resulting stereochemistry of the C2 hydroxide. Route e is the oxidation of the 
double bond into the epoxide with 3,3-dimenthyl-dioxirane, followed by subsequent 
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fluorination of the anomer with tetra-n-butylammonium fluoride in THF. The resulting glycosyl 
fluoride is the glucose derivative. Route f is fluorination, and hydroxylation, of the glycal 
directly. Shimizu reported that using water and phenyliodanediyldiacetatyl perfluorosilane 
(PhI(OAc)2-SiF4) will direct the fluoride α to the anomer, whilst hydroxylating the C2 position 
leads to the trans isomer thus, resulting in the fluoromannoside derivative (40) (41). 
 
 The reaction of glycosylfluorides as glycoside donors was recognised when 
Mukaiyama, Murai and Shoda discovered that activation of the fluoride as a leaving group 
could be achieved using tin (II) chloride and silver perchlorate. Fluorides can withstand harsher 
reaction conditions and have a significantly longer shelf life (9) (42). An example of the use of 
fluorides in carbohydrate synthesis is Ogawa’s synthesis of the Forssman antigen (Scheme 13 
and Scheme 29). Ogawa synthesised the Forssman antigen as a protected anomeric fluoride, 31, 
from the corresponding hemiacetal, 38, using DAST (35). He then proceeded to couple the 
Forssman antigen to the protected ceramide with SnC12 and AgOTf in dichloroethane in a 23% 
yield (16). This route demonstrates a versatile use for anomeric fluorides, not only in the 
delicate synthesis of the fluoride from a pentasaccharide, but in the glycosylation of the 
pentasaccharide with a ceramide residue. 
 
 
Scheme 29. Ogawa’s use of an anomeric fluoride. 
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1.1.2. Trichloroacetimidates 
  
Glycosyl-O-imidates were introduced by Schmidt in the early 1980’s when his 
research group developed the O-trichloroacetimidate as a glycoside donor. The 
trichloroacetimidate soon became one of the most widely used glycoside donors in 
carbohydrate synthesis (9).  
 
 
Scheme 30. Preparation of Schmidt’s trichloroacetimidate glycosyl donors. (9)(p144) 
 
 One of the attractive features of the trichloroacetimidate donor is its synthesis. Being 
a base induced reaction means that any constituents on the carbohydrate, such as acetonides 
or benzylidenes, which are acid labile, will remain untouched. The other attractive feature of 
the trichloroacetimidate is how it only requires catalytic amounts of the activating agent to 
achieve full departure of the leaving group. They are typically activated with TMSOTf (43) 
(Scheme 31). 
 
 
Scheme 31. The regeneration of the activating agent and mechanism of the 
trichloroacetimidate glycoside donor. 
 
 In Fengs’ synthesis of the Forssman antigen, from Section 1.1., Scheme 32, the 
versatility of the trichloroacetimidate was utilised in one of the syntheses of the α-OGalNAc-
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GalNAc terminal disaccharide, 24. Using the trichloroacetimidate was the most suitable donor 
in this situation. Synthesising the leaving group with potassium carbonate would not disrupt 
the acylated constituents on the amino galactoside. Coupling of the amino galactoside (21), 
with the other amino galactoside donor (22), already equipped with a thioglycoside leaving 
group, would proceed with catalytic amounts of the activating agent without activating the 
thioglycoside. In this way the galacto disaccharide 24 is generated as a protected thioglycoside 
donor, Scheme 32 (3). 
 
 
Scheme 32. Fengs’ use of the trichloroacetimidate. (3) 
 
 Feng claims that the conversion of the amino galactose hemiacetal into 21 was 
achieved with a yield of 76% using K2CO3 (3) (44). 
 
 Another feature of trichloroacetimidates that makes them versatile is that they can be 
activated by a range of compounds. Thus numerous studies have been carried out on the 
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anomeric product of glycosylation reactions using various metal complexes. Although the 
usual activating agent of choice is boron trifluoride diethyl etherate or trimethylsilyl 
trifluoromethylsulphonate (9), the ability of the nitrogen atom to act as a coordinating ligand 
means that anomeric imidates are a popular choice as the leaving group for studying the 
anomeric outcome of glycosylation reactions by varying the catalyst that activates the leaving 
group. For example, Nguyen reported the activation of trichloroacetimidates using ionic 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate to promote, a somewhat, stereoselective 
formation of manno, gluco and rhamno glycoside bonds. (45) They reported high α mannoside 
selectively, which is to be expected. But their glucoside selectively was almost exclusively β. 
They speculate that the reaction proceeds through a seven membered intermediate as outlined 
in Scheme 33. 
 
 
Scheme 33. Nguyen’s palladium (II) activated trichloroacetimidate. (45) 
 
 The rationale of this approach is that α selectivity of the mannosides arise mainly from 
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anomeric and steric effects as noted in Scheme 33. The glucosides β selectivity comes from a 
seven membered intermediate involving the palladium (II), the ether and the imidate 39. The 
acceptor can then attack the anomer from the β position. One drawback of the study is that the 
glycoside bonds formed are 1,2-trans, which can also be easily achieved through neighbouring 
ester group participation (45). The subject of stereocontrolling catalysis and chiral auxiliaries 
will be covered in more detail in section 1.2.2.2. Chiral Auxiliaries & Asymmetric Catalysis 
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1.1.3. Sulphur Based Leaving Groups 
1.1.3.1. Thioglycosides 
  
 Thioglycosides were first synthesised by Emil Fischer in 1909 as the S-phenyl 
derivative from the tetra-O-acylated bromo glycoside on treatment with sodium hydroxide and 
thiophenol (46). 
 
 
Scheme 34. Fischer’s thioglucoside. (46) 
 
 Although Fischer never described the mechanism, it can be assumed that the reaction 
proceeds by the SN2 substitution on the anomeric bromide. 
 
 Since Fischer’s discovery, there has been extensive research into the reactions of 
thioglycosides. Boons discovered that upon treatment with iodonium ion, thioglycosides can 
undergo anomerisation, although unlike the halogens which can anomerise with the 
corresponding tetra-butyl ammonium salt, the thioglycosides undergo their anomerisation via 
an intermolecular exchange (47) (9). Up until and Schmidts trichloroacetimidate method, 
thioglycosides were amongst the most used leaving group in carbohydrate synthesis. The 
thioglycosides can be activated by a number of different reagents and can be easily synthesised 
from the corresponding acetate. Thioglycosides can also be synthesised from the acetate via 
the oxocarbenium ion under Lewis acid conditions, using stannic (IV) chloride, or 
borontrifluoride etherate, Scheme 35.  
 
 
Scheme 35. Synthesis of thioglycosides using a Lewis acid. 
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 Obviously a setback of doing it this way is the lack of stereocontrol compared to 
synthesising them from the substitution of anomerically pure glycosyl bromides. But 
synthesising them this way does skip the step of brominating the per-O-acylated glycoside. 
 
 The usual agents for activating the coupling of a thioglycoside is by using N-
iodosuccinimide and trimethylsilyl trifluoromethanesulfonate/trifluoromethanesulfonic acid 
in greater than or equal to equimolar amounts. Other Lewis acids or halonium sources can be 
used to activate them depending on which R group (Scheme 35) is used (9). This can be 
especially useful when chemoselectively synthesising complex oligosaccharides. For 
example, anomeric 1,1-dicyclohexyl methylene sulphide (IDCP) is resistant through steric 
hindrance to activation under the same conditions as that of the corresponding anomeric ethyl 
sulphide (48).  
 
1.1.3.2. Glycosyl Sulphoxides and Sulphones. 
 
 Thioglycosides can be oxidised into the corresponding sulphoxide. This was achieved 
by a reaction of the thioglycoside with hydrogen peroxide in the late 1930s by Micheel and 
Schmitz. It can proceed without protecting groups and in wet conditions and yields a single 
(S) sulphonyl stereoisomer (Scheme 36) (49). 
 
 
Scheme 36. Micheel and Schmitz sulphoxide. (49) 
 
 Glycosyl sulphoxides can also be synthesised from the thioglycoside by oxidation with 
meta-chloroperoxybenzoic acid (mCPBA). They can then be reduced into the corresponding 
glycal. Gomez describes a method to synthesise both the furanoglucals and pyranoglycals 
from the sulphoxide by treatment with n-butyllithium (Scheme 37).  
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Scheme 37. Reduction of the sulphoxide to the glycal. 
 
 Gomez reduced the glycosyl sulphoxide to the glycal with n-butyllithium using a 
deuterium labelled system to deduce the mechanism. Their experiments resulted in a C1 
deuterium present in the glycal product leading them to propose that the C1-C2 trans lithium 
compound 40 is responsible for the elimination reaction, proceeding regardless of the starting 
anomer. The C2 methoxide can leave as the lithium salt, whereas the propylidene can leave as 
acetone and lithium hydroxide (50).  
 
 Glycosyl sulphoxides have been used in glycoside bond forming reactions by 
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activation with several different compounds, but the most popular is triflic anhydride and a 
catalytic amount of a hindered base such as 2,6-di-tert-butyl-4-methylpyridine (DTBMP). Use 
of triflic acid as an activator, with catalytic methyl propiolate has also been used to activate 
glycosyl sulphoxides (Scheme 38) (51).  
 
 
Scheme 38. The glycosylation reaction of glycosyl sulphoxides with triflic acid or the 
anhydride. (51) 
 
 Thioglycosides can be oxidised further into the corresponding sulfones by treatment 
of the sulphide with potassium permanganate (52). Once oxidised to the sulfones, they can be 
chemoselectively activated in the presence of a thioglycoside acceptor, to synthesise a 
disaccharide thioglycoside donor (Scheme 39). Lowery displayed that this is possible using 
samarium (III) triflate to activate a pyridyl sulphone (53). 
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Scheme 39. Synthesis of a disaccharide using chemoselective activation of a sulphone. (53) 
 
 Lowery reported α:β selectivity of 3:1 from their samarium (III) triflate glycosylation 
and then 1.4:1 selectivity for the NIS and silver triflate coupling. They rationalise the selective 
activation of the pyridyl sulphone by its ability to coordinate to the samarium (III) ion through 
the sulphonyl oxygen and the pyridyl nitrogen. Thus drastically increasing the reactivity of the 
anomeric sulphone (53). 
 
 Another attractive property of the thioglycosides is their unique response to the armed-
disarmed effect. The armed-disarmed effect, Scheme 40, was initially observed by Fraser-Reid 
(54), who noticed that the rate of oxocarbenium ion formation is influenced by the nature of the 
protecting groups on the glycoside donor. Both esters (electron withdrawing) and cyclic acetals 
(torsionally constraining) slow the rate of oxonium formation which in turn retards the rate of 
glycosylation. Interestingly the electronic effect is found to be stronger with anomeric sulphides 
than the corresponding n-pentenyl ether  (9). 
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Scheme 40. The armed disarmed effect. 
 
 The rationale of this effect is believed to be as follows; a neighbouring ester group 
strips electron density from the anomeric leaving group, making the chelation of the leaving 
group (LG) with its activating agent less likely to occur, thus lowering the rate in which the 
oxocarbenium ion is formed. Torsional disarming is relatively easier to rationalise in 
comparison; the oxocarbenium ion and its hexene-like conformers have their energy levels 
drastically increased due to cyclic protecting groups, thus decreasing the rate in which the 
oxocarbenium ion is formed. Comparatively torsional disarmed glycosides react slower than 
electronically disarmed glycosides (54) (55) (56).  
 
 
 
Scheme 41. Armed-disarmed effect giving rise to chemoselective glycosylation. (57) 
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 The best example of how this effect can be exploited synthetically, is the chemoselective 
activation with stoichiometric amounts of activating agent (Scheme 41). For example, the 
coupling of ethyl thioglucoside donor 41 with the partially protected ethyl thioglucoside donor 
42 using equimolar amounts of donor and acceptor proceeds to generate disaccharide 43 
exclusively, with no self-condensation product 44 being observed (57). 
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1.1.4. N-Pentenyl Glycosides 
 
 Fraser-Reid initially introduced n-pentenyl glycosides in disaccharide synthesis in the 
late 1980s, although the initial intention of the n-pentenyl group was as a protecting group for 
the anomeric position. Fraser-Reid was quick to realise the potential as a leaving group and 
utilise the reaction in carbohydrate synthesis (58). They are easily synthesised from the 
corresponding per-O-acylated glycoside, 4-penten-1-ol and a Lewis acid, in a similar fashion 
to the synthesis of thioglycosides shown in Scheme 35. They can also be synthesised via the 
Fischer glycosylation shown in Scheme 4, using the 4-penten-1-ol instead of methanol  (59). 
Or they can be synthesised from the corresponding halide, similar to reactions discussed in 
Scheme 15, Scheme 16, Scheme 18 and Scheme 24 (60). Glycosylation using n-pentenyl donors 
is called ‘trans-glycosidation’ in that the donors anomer is in a glycoside bond with n-pentenyl 
ether and the product of the reaction is simply a different glycoside bond (9). The action of n-
pentenyl ethers is based on a reaction from the turn of the 20th century called 
iodolactonisation, or halolactonisation (Scheme 42).  
 
 
Scheme 42. Bromolactonisation of 4-penten-1-oic acid. 
 
 Bromolactonisation was first recognised in 1902 by Stobbe, its reaction being base 
induced with analogues of n-pentenyl acid. The bromonium ion was formed from N-bromo 
succinimide (NBS) and the base used was sodium carbonate. Once the γ, δ-unsaturated bond 
forms the bromonium ion, the acid anion would then proceed to attack the γ carbon 
intramolecularly in the formation of a 5-membered lactone ring. It was found by Fraser-Reid 
that instead of liberating a proton from the acid, it was possible that the anomeric ether could 
liberate an oxocarbenium ion once activated in a similar reaction with NIS, but without the 
need for sodium carbonate (Scheme 43). Fraser-Reid’s reaction is not iodolactonisation 
because the product is a tetrahydrofuran, and not a lactone due to the lack of the carbonyl. The 
typical activating agent for n-pentenyl glycosides is NIS and TMSOTf, but they can be 
activated with just NIS (14). 
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Scheme 43. Fraser-Reid’s n-pentenyl glycoside. 
 
 The intramolecular cyclisation of the n-pentenyl ether gives solely the methyl 
tetrahydro furan product 45a and not the iodo tetrahydropyran product 45b. This conforms 
with Baldwin’s rule for favoured and disfavoured products of cyclisation as a favoured 5-exo-
tet cyclisation. Whereas the 6-endo-tet product is disfavoured. These are called 5/6 because of 
the size of the ring formed, exo/endo because of the orientation of the bond broken, where it 
could be outward of the ring (exo) or inward (endo). And ‘tet’ because of the tetrahedral 
hybridised orbitals of the carbon being attacked (61). 
 
 As mentioned earlier, Fraser-Reid used his n-pentenyl glycoside in the discovery of the 
armed – disarmed effect, where he compared the rate of anomeric hydrolysis of alkyl protected 
n-pentenyl glycosides to that of ester protected n-pentenyl glycosides. He found that the C2 
benzylated n-pentenyl glycosides hydrolysed to the corresponding anomeric hydroxyl several 
orders of magnitudes faster than that of the corresponding ester (54). He proceeded to test his 
theory in the synthesis of a trisaccharide ( 
Scheme 44). 
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Scheme 44. First application of the armed-disarmed effect. (54) 
 
 An attractive property of n-pentenyl glycosides is their ability to have the leaving groups 
terminal alkene protected as a 4,5-dibromoalkane, which can be easily turned back into the 
alkene. This allows for a pseudo chemoselective approach to oligosaccharide synthesis. Fraser-
Reid used this methodology in the rather elegant, convergent, 2+2 synthesis of a branched 
tetrasaccharide from the cap of the Leishmania lipophosphoglycan (Scheme 45) (62). 
 
1. Introduction   
 59 
 
 
Scheme 45. Fraser-Reid’s synthesis of the Leishmania lipophosphoglycan cap. (62). 
a) 46, 47, NIS, DCM b) Thiourea, NaCO3, EtOAc, c) 49, Br2, TBAB, DCM, d) NaOMe, 
MeOH, e) 49, 50, NIS, DCM, f) 51, Zn, TBAI, DCM, g) 48, 52, NIS, DCM. 
 
 Fraser-Reid synthesised the β-O-Gal-1-4-Man 48 from the per-O-acylated n-pentenyl 
galactoside 46, and a brominated 2-chloroacetyl-3,6-dibenzyl n-pentenyl mannoside 47. This 
showed how it is possible to activate the n-pentenyl anomer without affecting its 
corresponding brominated counterpart on 47, then selectively deacylating the chlorinated 
acetate with thiourea and sodium hydrogen carbonate in ethylacetate, thus generating a 
disaccharide acceptor 48. They then proceeded to synthesise the α-O-Man-1-2-Man 
disaccharide donor 52 from mannoside donor 49, which was easily converted into the acceptor 
50 by bromination of the n-pentenyl leaving group, with TBAB and bromine, and deacylation 
of the acetate. Coupling 49 with 50 yielded the 4,5-brominated n-pentenyl disaccharide 51. 
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Which is then easily de-brominated into the n-pentenyl alkene leaving group, with TBAI and 
zinc dust, thus generating the disaccharide donor 52. Finally coupling of n-pentenyl glycoside 
52 with 48, the brominated acceptor, would furnish the branch tetrasaccharide 53 (62). 
  
 In terms of glycoside bond formation, we have only so far discussed activation 
methods. However, unlike a peptide coupling, there are two possible diastereomeric products 
(anomers) from a glycosylation reaction. Like all bond forming reactions involving the 
generation of a new chiral centre there is intense effort focussed around the discovery of a 
stereocontrolled version of the reaction, and indeed asymmetric glycosylation has seen major 
efforts over the last twenty years to deliver stereocontrolled glycoside bond formation. 
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1.2. Stereocontrol 
 
 As mentioned in the previous sections on anomeric leaving groups, the stereochemical 
outcome of glycoside bond formation is of the upmost importance in oligosaccharide 
synthesis. Over the years, since glycoside bond forming reactions were first introduced into 
organic chemistry, there have been numerous investigations into the factors affecting anomeric 
control. These have included solvent effects, the use of protective groups, temporary tethers, 
specially designed donors and chiral catalysts to name a few. This section will provide a brief 
review on some of these attempts to deliver a rational approach asymmetric glycosylation. 
 
1.2.1. Neighbouring Group Participation  
  
 The most basic way of controlling the stereochemistry of a glycoside bond is through 
neighbouring group participation of an ester in the formation of trans glycoside bonds (Scheme 
46). They also happen to be part of the armed-disarmed effect. 
 
 
Scheme 46. Neighbouring ester participation in trans glycosylation. 
 
 The carbonyl on the C2 ester acts upon the oxocarbenium ion in sharing its charge, 
whilst simultaneously preventing attack of the acceptor from the cis position. Ogawa took 
advantage of this method in his synthesis of the stage specific embryonic antigen-3 (SSEA-3) 
(63), globopentaosyl ceramide. A similar pentasaccharide to that of the Forssman antigen from 
Figure 2, but different in that its terminal galactoside is not an α-2-amino galactoside, but a β-
galactoside (Scheme 47). Ogawa used the neighbouring ester 2,4,6-trimethylbenzoyl (TMBz) 
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because its trans selectivity is especially prominent when compared to the other esters 
available (63). 
 
 
Scheme 47. Ogawa’s stereo controlling C2 O-TMBz. (63) 
 
 Ogawa found the trans, in this case β, selectivity to exceed the selectivity of a 
neighbouring benzoyl group, which itself shows greater selectivity than the acetate (63). An 
important factor, besides neighbouring group participation, to take into account when using 
esters to protect the C2 hydroxyl is whether or not they can be chemoselectively de-protected 
in the presence of other esters. Fraser-Reid demonstrated the use of a 2-chloroacetate 
neighbouring ester (Scheme 45) which is selectively removed from the disaccharide 
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glycosylation product, which contained acetate substituents on the carbohydrate, using thiourea 
and sodium hydrogen carbonate (63). Ogawa also demonstrated the use of the 2-chloroacetate 
as a neighbouring group stereocontrolling auxiliary to a chloride donor in the di-mannosylation 
of a di-hydroxy acceptor (Scheme 48). The oligosaccharide synthesised was part of a study in 
synthesising branched high-mannose type glycopeptides. Ogawa was able to create two 
glycoside bonds simultaneously onto the same acceptor, 54, with remarkable trans 
stereoselectivity (64). 
 
 
Scheme 48. Di-mannosylation using 2-chloroacetate to control the stereochemistry (64).  
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 The use of a C-2 ester to deliver what is often referred to as a trans 1,2 glycoside is 
relatively straight forward. However, Boons has recently reported an elegant refinement of 
neighbouring group participation to synthesise the more difficult to access cis-glycoside using 
the (1S)-phenyl-2-(phenylsulfanyl) ethyl protecting group. The method works through a 
temporary six membered cyclic attack of a phenyl sulfide to the oxocarbenium ion. The (1S)-
phenyl lies in an equatorial conformation, meaning the oxocarbenium has its β face blocked, 
thus attack of the acceptor to the oxocarbenium ion has to occur from the α position (Scheme 
49). 
 
 
Scheme 49. Boon’s neighbouring group participation. 
 
 The key problem with this method is that enantiomerically pure reagents can be costly. 
Luckily for Boons method, the (1S)-phenyl-2-(phenylsulfanyl) ethyl group was relatively easily 
synthesised from readily available (S)-mandelic acid (Scheme 50). Treatment with LiAlH4 
would afford the diol 55. Of which the primary alcohol is then selectively tosylated and finally 
substituted with phenylthiol to generate the sulfide 56. The secondary alcohol is then acylated 
with acetic anhydride and pyridine to give ester 57 which is attached to the C-2 hydroxyl using 
Lewis acid catalysis to give monosaccharide 58. 
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Scheme 50. The synthesis of Boon’s (1S)-phenyl-2-(phenylsulfanyl) ethyl neighbouring group 
(65). 
 
 To attach it to the glycoside, the acetate is then activated with BF3·OEt and substituted 
with the sulphide in the formation of an epi-sulphonium ion, 57b, which is substituted with 
the glycosides C2 hydroxide. The subsequent ether formed retains the chirality of the original 
acetate Scheme 51 (65). 
 
 
Scheme 51. The mechanism of epi-sulphonium ion formation. 
 
 The carbohydrate hydroxyl group attacks the episulphonium ion at the benzylic carbon 
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as opposed to the primary carbon because the benzylic carbon will better stabilise the 
developing positive charge than the primary carbon, thus making it more electrophilic. Not 
only that, but resonance structures can be drawn due to the nature of the benzylic carbon group 
stabilisation 57c, which adds to its ability to stabilise the charge. (66).  
  
 Unfortunately, this method has limitation in that it will not work with mannosides or 
related systems where the C2 substituent is in the axial position. This is because the six-
membered intermediate would have to suffer strain in order to form the trans decalin 
intermediate 59 (67), if any of the cis decalin forms then the product would be a trans 
mannoside, which is already easily achieved with an ester on the C2 position (Scheme 52). 
 
 
Scheme 52. Boon’s neighbouring group direction with mannosides. 
 
 A year later Boons followed up with a study of the use of ethyl 2-bromo-2-phenyl 
acetate as a protective group, with emphasis on the effect of stereochemistry on the outcome of 
a chimerically assisted glycosylation. As Scheme 53 outlines the S enantiomer is expected to 
direct the acceptor to give a disaccharide in a cis orientation, whereas it would be realistic to 
assume that the R enantiomer would direct the glycosylation into the trans orientation. 60S and 
60R are the S and R enantiomers at the neighbouring groups phenyl group, respectfully. 62 and 
its variations, are the intermediates that the glycosylation reaction could go through as a result 
of attack from the neighbouring groups carbonyl (61). 62Sb and 62Rc are the most hindered 
cyclic intermediates of the corresponding donor, whereas 62Sa and 62Rd are the least hindered 
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intermediates, and display stereochemical control of the reaction. 
 
 
 
Scheme 53. Boon’s neighbouring group participation using both R and S enantiomers (65). 
  
 For their study they used an array of variously protected donors. As an example of the 
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results, the following reactions were performed used a glucoside trichloroacetimidate as the 
donor and a diacetone galactose as the acceptor (Scheme 54 and Scheme 55).  
 
 
 
Scheme 54. Selectivity observed from the S enantiomer of Boons neighbouring group study. 
 
 
 
Scheme 55. Selectivity observed from the R enantiomer of Boons neighbouring group study. 
 
Scheme 54 shows the stereoselectivity of the ‘S’ donor and Scheme 55 shows the 
stereoselectivity of the ‘R’ donor. Both schemes also how changing the C3 protecting group of 
the donor curiously affected the outcome of the glycosylation considerably. The S enantiomers’ 
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cis selectivity was not as consistent as the R enantiomers’ trans selectivity upon changing the 
C3 protecting group, 63S being the notable example. Not only was this an interesting study of 
the stereocontrolling ability of a chiral C2 group, but also how a substituent on the glycoside 
donor five bonds away from the anomer can still effect the stereoselectivity of the glycoside 
bond formed. Within the same study similar findings were observed with a galactoside donor 
and a C4 glucoside acceptor, as highlighted in  
 
Scheme 56. 
 
  
 
Scheme 56. Boon’s neighbouring group participation on galactosides (65). 
 
 The neighbouring group participation was nearly as effective on the glucoside as it was 
on the galactoside. Not only does this research demonstrate an effective measure to nearly 
complete stereo control, but it also shows evidence for how more distant substituents on the 
glycoside donor affected the outcome of the glycosylation reaction. Structurally the galactoside 
donor differs from the glucoside donor by an axial component five bonds away from the 
anomer. 
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 Xue-Wei Liu has also worked on the development of a novel protecting group to control 
stereochemistry. He reported the use of a C2 ortho cyanobenzyl group to aid in the stereocontrol 
of glycoside bond formation as outlined in Scheme 57. 
 
 
Scheme 57. Xue-Wei Liu’s neighbouring ortho cyanobenzyl group for trans synthesis (68). 
 
 Their proposed mechanism involves an energetically favoured nitrilium ion 64b, 
which mimics the nitrile effect in directing the acceptor into the β position (9). The most 
interesting aspect of their discovery is that the reverse effect is observed when the acceptor’s 
hydroxide is losing electron density, or the nucleophilicity of the oxygen is decreased by a 
massively electron withdrawing group such as acylated glycosidic acceptors or poly 
fluorinated alkyl acceptors. Glycosylation of thioglucoside 64 with methyl 2,3,4 tri-O-benzyl 
α-D-glucopyranoside acceptor gives only the β (trans) anomer, whereas the reaction of 64 
with methyl 2,3,4 tri-O-acyl α-D-glucopyranoside yields only the α (cis) anomer. The same 
anomeric selectivity is observed with the aglycone butanol and 2,2,2,-trifluoroethanol 
respectively. The β selectivity observed conforms to the mechanism proposed in Scheme 57. 
The α selectivity is considered to be as a result of the nitrile anchoring via a hydrogen bond to 
the acceptors hydroxide group through the hydrogen atom. Which then allows the oxygen to 
attack the oxocarbenium ion from the α orientation, as outlined in Scheme 58. 
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Scheme 58. Xue-Wei Liu’s neighbouring ortho cyanobenzyl group for cis synthesis (68). 
 
 The hypothesis was supported by the observed reaction of the nitrilium ion 64b with 
2-chlorobenzoic acid, trapping the nitrilium ion as its corresponding imidate 65 solely in the 
α conformer, outlined in Scheme 59: 
 
 
Scheme 59. Xue-Wei Liu’s supporting reaction (68). 
 
 Computational results suggest that the eight membered nitrilium ring 64b could be 
favoured over the direct β glycosylation intermediate by 13.37 kJ mol-1, both of which were 
found to be more favoured than the free oxocarbenium ion 64a by 7.37 kJ mol-1 (68). 
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1.2.2. Environmental effects 
 
 It is possible to control the stereochemical outcome of a glycosylation reaction by 
manipulating the environment in which the reaction is performed. Two examples of this can be 
by either changing the solvent or adding a chiral auxiliary to the reaction medium. Modifying 
the catalyst can also effect the stereo outcome of a glycoside bond. 
 
1.2.2.1. Solvent Effects  
  
 The solvent effect, or sometimes referred to as the nitrile effect, originated from the 
use of acetonitrile as a solvent for a glycosylation reaction. The acetonitrile acts upon the 
oxocarbenium ion in the α orientation, 66, during which, the acceptor can only approach the 
anomer from the β face. As briefly mentioned in 1.1.1. Anomeric Halides, Scheme 17. The 
nitrile forms a nitrilium ion on reaction with the oxocarbenium species and the resulting 
intermediate vastly predominates in the α configuration. This means that the acceptor attacks 
chelated species 66 at the equatorial position to give the β glycoside. 
  
 
Scheme 60. The nitrile effect (9). 
 
 It would therefore be realistic to assume that having more electron donating ability 
within the solvent molecule could lead to a greater nitrile effect, and more of the final 
glycoside product would be formed in the β conformation. Nakahara and Hojo published a 
series of directly comparable reactions in methylene chloride, acetonitrile and propionitrile as 
solvents, showing a respective increase in β glycosylation (Scheme 61) (69) as the electron 
donating ability of the solvent increased.  
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Scheme 61. A comparison of the solvent effect on glycosylation stereochemistry. 
 
The reaction explored was that of a 1-benzenesulfinyl piperidine 
trifluoromethanesulfonic anhydride 2,4,6-tri-tertbutylpyrimidine (BSP-Tf2O-TTBP) promoted 
(70) glycosylation of a tetra benzyl phenyl thio galactoside with no participating group at the 
C2. The results clearly show a direct correlation between increasing the electron donating 
ability of the solvent and β selectivity. 
  
 Hashimoto published a more in-depth table comparing glycosylation reactions 
performed in acetonitrile or diethyl ether, however this time the solvent interaction of diethyl 
ether acted upon the oxocarbenium in an opposite manner (71) (Scheme 62).  
 
 
Scheme 62. Solvent effect of diethyl ether. 
  
 Their reaction was a modification of the Koenigs–Knorr reaction in which the donor 
was a 2,3,4,6-tetra-O-benzyl glycoside fluoride and trimethyl silyl methoxide as the acceptor, 
promoted by TMSOTf. They directly compared the same reactions in acetonitrile and diethyl 
ether. As well as other reactions and coupling reactions. As outlined in Scheme 63, α selectivity 
was observed to be favoured when the glycosylation reaction was performed in diethyl ether 
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compared to acetonitrile which favoured the  anomer (71). 
 
 
 
Scheme 63. Nitrile vs Ether effect (71). 
  
  
1.2.2.2. Chiral Auxiliaries & Asymmetric Catalysis 
 
 An interesting approach to stereocontrolled glycosylation is the development of a chiral 
catalyst that is both capable of activating the donor and chelating, and therefore directing the 
acceptor. Trichloroacetimidate donors are particularly useful for this kind of glycosylation 
system (see Scheme 30) due to the acetamides ability to coordinate through its nitrogen atom 
(9) (45).  
  
 An obvious experiment to test whether stereocontrol of the glycoside bond is possible 
by manipulation of the activating agent is the use of chiral acids. Fairbanks published a study 
on the effect of chiral acids as activating agents for trichloroacetimidates. The acid used was 
(11S)-2,6-bis (3,5-bis(trifluoromethyl)phenyl)-4-hydroxydinaphtho [2,1-d:1',2-f] [1,3,2] 
dioxaphosphepine 4-oxide as 67S/R enantiomers. A galactoside trichloroacetimidate donor, 68, 
was used with a 6-hydroxyglucosyl acceptor, comparing the standard TMSOTf activation with 
the 67S/R enantiomers of the phosphoric acids, as outlined in Scheme 64.  
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Scheme 64. Fairbanks' chiral phosphoric acid glycosylation (72). 
 
 Their findings showed that the two enantiomers did not show opposite anomeric 
selectivity, rather the S enantiomer showed slightly greater selectivity than the R enantiomer, 
with both favouring the formation of the β anomer. Nevertheless, the chirality of the activating 
agent did affect the anomeric outcome of the glycosylation (72). 
  
 A year later Schmidt reported the use of difluoro(phenyl)borane as a promoter for 
trichloroacetimidates that directed the acceptor into the trans position, as outlined in Scheme 
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65. 
 
Scheme 65. Schmidt’s difluoro(phenyl)borane activator (73). 
  
 The difluoro(phenyl)borane forms an adduct with the glycoside acceptor, 69, which 
then activates the trichloroacetimidate and delivers the glycoside acceptor to the anomer 
inverting the stereochemistry of the donor in an SN2-type reaction. Their results showed 
significant stereoselectivity when compared with the more traditional methods of activation 
and the stereoselectivity increased with lower temperatures suggesting that less of the 
oxocarbenium ion, in the SN1 type reaction, is formed (73).  
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1.2.3. Intramolecular Glycoside Bond Formation 
 
 Intramolecular aglycone delivery, is a method of synthesising a glycoside bond by 
temporary attachment of an acceptor to a donor by means other than a glycoside bond. 
Migration of the acceptor to the anomeric position then occurs in a controlled manner to effect 
glycosylation. The method was applied to glycoside synthesis with the belief that using the 
other substituents to ‘deliver’ the aglycone to the anomer via a cyclic intermediate could 
control the stereochemistry of the glycoside bond formed. 
  
 One of the earliest examples of intramolecular aglycone delivery was developed by 
Barresi and Hindsgaul in 1994 (74). Their research provided the basis for further investigation 
into the use of temporary tethers to control stereoselective glycosylation. 
 
 
Scheme 66. Hindsgaul’s intramolecular aglycone delivery (74). 
 
 This method uses a carbon tethering system, which proceeds via toluene sulphonic acid 
activation of C2 glycosidic isopropylene 70, outlined in Scheme 66, to give the tethered system 
71. NIS promoted glycosylation then proceeded via the proposed intermediate 72 to give, after 
aqueous workup, disaccharide 73 as the β anomer. Hindsgaul has suggested that the mechanism 
is a concerted process rather than a stepwise one which involve the classical oxonium ion 
associated with standard glycosylation chemistry. Thus activation of donor 71 is accompanied 
by simultaneous migration of the tethered acceptor to produce cyclic intermediate 74 which 
then collapses to form disaccharide precursor 72. Finally, hydrolysis of 72 produces 
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disaccharide 73 via intermediate 75 (Scheme 67). 
 
 
Scheme 67. Hindsgaul’s mechanism of intramolecular aglycone delivery (74). 
 
 They reported unoptimised reaction yields of up to 61% with six equivalents of NIS 
(74). More importantly however they laid out a series of optimisation targets involving study 
of the tethering system, the donor type and the method of activation, all of which should lead 
to an important methodological addition to asymmetric glycosylation. This seminal paper 
initiated a major research effort into intramolecular aglycone delivery, so much so that we can 
divide the methodology into three main categories based on the type of aglycone delivery 
system. These are: 
 
I. Neighbouring group participation (as mentioned above and the key part of our study) and 
intramolecular delivery 
II. Spacer-mediated 
III. Leaving group self-displacement. 
 
1.2.3.1. Spacer-mediated  
  
 Spacer-mediated glycosylation, outlined in Scheme 68, involves the delivery of the 
acceptor to the anomeric position from a linker that attaches to both the acceptor and donor. 
The glycoside acceptor can bind onto a spacer moiety already arranged on the glycoside donor, 
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then migrate to the anomeric position upon activation, leaving the spacer intact. In other words, 
the cyclic arrangement of the acceptor and donor is isolable, and not just an intermediate. 
Ziegler et al describe a way of controlling the stereo selection of a 1,2,-cis glycoside bond 
between a galactoside donor and glucoside acceptor. The glucose acceptor 77 and the galacto 
donor 76 both react with butan-dioic acid, in the presence of the coupling agent DCC to generate 
the tethered dimer. The benzylidine is then reduced to a C6 benzyl ether 78, leaving the C4-
hydroxyl free, which attacks the oxocarbenium ion upon activation of the thiol 79, as outlined 
in Scheme 68 (75).  
 
 
 
Scheme 68. Ziegler’s spacer mediated 1,2-cis glycoside bond formation (75). 
 
 An eleven membered glycosidic ring was isolated, which spans the 1,2 positions (in a 
cis configuration) of the donor, and the 3,4 positions of the acceptor. The di-ester spacer can 
then be hydrolysed, to yield the disaccharide 80 connected only by the resulting glycoside 
bond. Similar to this spacer mediated intramolecular aglycone delivery, the “rigid spacer 
glycosylation” was a method proposed by Schmidt in 1998 (76) (Scheme 69), whereby the 
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spacer is attached to the C6 position of the donor as a meta substituted bromo di-benzyl 
functionality 81. As with Ziegler’s approach, Schmidt attached the donor through the C3-OH 
of monosaccharide 82 to give linked system 83. Reduction of the benzylidene protecting group 
in 83 gave the linked donor/acceptor pair 84 which, under standard glycosylation conditions 
produced disaccharide 85 as the β anomer. Finally, hydrogenolysis of all the remaining 
protecting groups and acylation of the hydroxyls furnished disaccharide 86 (Scheme 69). 
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Scheme 69. The rigid spacer glycosylation (76). 
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1.2.3.2. ‘Self-displacing’ glycosylation 
 
 A further introduction to the area of intramolecular aglycone delivery was the 
development of the ‘self-displacing’ leaving group. In this approach the acceptor is linked to 
the anomeric hydroxyl group by means of a temporary tether which can then be activated to 
initiate a glycosylation similar in approach to intramolecular aglycone delivery. The main 
difference is that the tether is also acting as the leaving group, hence the self-displacement 
terminology. This method has not shown any level of stereocontrol yet, but it is still relevant 
as a concept and its further development could lead to the ability to deliver a 1,2-cis glycoside 
synthesis (77). 
 
 
Scheme 70. ‘Self-displacing’ glycosylation. 
 
 Scheme 70 describes the generic approach to leaving group self-displacement 
glycosylation. In this example the tether is placed at the anomeric position of donor 87, with 
the acceptor 88 having a free hydroxyl group, although it should be noted that methodology 
utilising a ‘role reversal’ is also possible. A coupling reaction between 87 and 88 produces 
linked disaccharide 89 which, following activation via intermediate 90, produces disaccharide 
91. It has been proposed that the mechanism of glycosylation is concerted in nature and 
therefore, as shown for 90, the ‘α tether’ should produce the β disaccharide in a 
stereocontrolled manner. 
 
 The reactions of carbonic tethers, described by Schmidt in 1997 (78), has however 
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challenged this theory, Schmidt investigated the reactions of decarboxylative anomeric tether 
whereby the delivery of the glycoside bond could either proceed intramolecularly, or 
intermolecularly, from an anomeric carbonic tether, as Scheme 71 outlines. 
  
 
Scheme 71. Schmidt’s attempt at a ‘self-displacing’ glycosylation. 
 
 The results of this study were inconclusive, although Schmidt did suggest that 
glycosylation could be occurring through competing inter and intramolecular pathways and 
concluded that further research on the reaction could lead to a controlled intramolecular 
reaction.  
 
Mukai and Hanaokas have also investigated the self-displacement approach based on 
a cobalt mediated glycosylation as shown in Scheme 72. Their reaction takes advantage of the 
fact that complexation of dicobalt hexacarbonyl to alkynes produces a species capable of 
stabilising an adjacent carbocation. Thus acceptor 18 was converted, in a series of steps, into 
alkynyl glycoside 92 which was subsequently transformed into tethered disaccharide 93. It 
was expected that TMS triflate promoted glycosylation should proceed, with concomitant 
lactonisation, via the bicyclic intermediate 94 to deliver a β mannoside. However, it appears 
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that the reaction again proceeds intermolecularly as suggested by structure 95 which simply 
leads to a classical donor/acceptor pair that couple to produce the disaccharide as a mixture of 
anomers [76]. 
 
Scheme 72. Mukai and Hanaoka’s alkyne – cobalt glycosylation [76].  
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1.2.3.3. Intramolecular Delivery 
 
 Fairbanks has developed a notable carbon tethering aglycone delivery system, as 
outlined in Scheme 73. Their method, of propargyl mediated intramolecular aglycone delivery 
[77] proceeds via treatment of the C2 propargyl ether of glycoside 96 with potassium tert 
butoxide to form the allene 97. Coupling of 97 with acceptor 98 using an iodonium source 
gave the tethered dimer 99 which, under standard glycosylation conditions, gave disaccharide 
100 exclusively as the β anomer in an excellent yield of 81%.  
 
 
Scheme 73. Propargyl mediated intramolecular aglycone delivery (79). 
 
 Other aglycone delivery systems arise in the literature that do not proceed through the 
use of a carbon tether. Stork developed an intramolecular delivery system that implemented a 
silicon tether (80). as outlined in Scheme 74. This reaction proceeds via a temporary silyl tether 
that is generated between 101 and 102 to give a tethered dimer. Oxidation with mCPBA of the 
thioether leaving group to yield sulfoxide 103 which was allowed the oxocarbenium ion 
formation from triflic anhydride and 2,6-di-tert-butylpyridine activation of leaving group to 
give 104, the temporary silyl tether is then cleaved with an aqueous work up to yield 105. 
Glycosylation was achieved with full stereo-selection, in yields of up to 68% (80). 
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Scheme 74. Intramolecular aglycone delivery via a temporary dimethyl silyl tether (80). 
 
  Ogawa proposed a method of aglycone delivery in the synthesis of β mannosides that 
utilised the DDQ activation of a donor C2 para-methoxy benzyl (PMB) group. It is possible 
to oxidise the PMB group of donor 106 to the corresponding oxonium ion 107 which is then 
trapped with an alcohol to give mixed acetal 108. Upon activation of the leaving group a now 
familiar intramolecular aglycone delivery occurs to give disaccharide 110 via intermediate 
109 (Scheme 75) (81) (82). 
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Scheme 75. Ogawa’s PMB/para benzyl O-linked polymer aglycone delivery[80]. 
 
 Problems however have been reported due to the lability of mix acetal 108 which have 
resulted in excessive hydrolysis. Ogawa has, in part, resolved these issues by utilising a 
polymer supported system (see 107b) which simplifies the purification of any acetal 
intermediates [80]. 
 
 Fairbanks developed a notable intramolecular aglycone delivery (IAD) system as an 
advancement of Hindsgauls IAD (Scheme 66). They utilised a neighbouring ethylene group, 
which was then reacted with NIS and the acceptor 111 to yield the donor – acceptor dimer 
112. Final activation of the donor with AgOTf allowed the acceptor to migrate into the anomer 
in a stereocontrolled orientation.  
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Scheme 76. Fairbanks’ ethylene mediated IAD. 
 
 They reported a 52% yield of 113 as the α anomer. Within their study, they surveyed 
other donor and acceptor systems the best result with a mannose donor, similarly protected 
and reacting with the glucose acceptor 18 in the synthesis of disaccharide 114 to produce 79% 
of the β anomer. 
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2.0. Aims 
 
 As has been pointed out in the preceding literature review there have been a number 
of attempts at controlling the stereochemistry of glycosylation and, more specifically, the 
control of the 1,2 cis-glycoside. Unfortunately, most of the examples suffer from drawbacks 
such as the rather cumbersome three-step tether approach of intramolecular aglycone delivery 
or have only met success within a limited substrate set. We envisioned the development of a 
general approach to asymmetric glycosylation through the use of a sacrificial protecting group 
that is capable of delivering the aglycone in a stereocontrolled manner via a mechanism that 
we are calling neighbouring group direction. As a key feature, asymmetric glycosylation 
would occur in one step rather than the two step tether and separate glycosylation strategy 
associated with IAD (vide supra). 
 
 
Scheme 77. Proposed approach to a novel neighbouring group direction. 
 
 Scheme 77 outlines our general strategy in which monosaccharide 115 is protected at 
C-2 with a mixed acetal. The structure of the mixed acetal is notable in that it houses a leaving 
group (LG) identical to the anomeric donor group that will also be used to effect the 
glycosylation reaction. The principle behind this strategy then is, like the armed-disarmed 
effect, simply based on the differing rates of oxonium ion formation. Thus treatment of donor 
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115 with two equivalents of activator would initially lead to the formation of the more stable 
benzylic oxonium species 116 (66) which would then immediately react with the aglycone to 
form a second mixed acetal 117. The second equivalent of activator now acts on the anomeric 
donor to produce cyclic oxocarbenium species 118 which undergoes a familiar aglycone 
delivery to produce the 1,2 cis glycoside 119 in a highly controlled fashion. Thus, approach 
of the acceptor to the anomer and formation of the glycoside bond will be directed via the 
neighbouring oxocarbenium into a cis configuration. This new approach, if successful, would 
provide a novel approach to controlling the stereoselectivity of a glycoside bond, as a one-pot 
intramolecular aglycone delivery. At the outset we had assumed that the mixed acetal would 
act as a protecting group and, after participating in the glycosylation reaction would hydrolyse 
upon aqueous work-up of the reaction; hence the term ‘sacrificial’ protecting group. 
 
It is possible to expand upon the initial idea, not only by using arylic acetals to provide 
added stability to the neighbouring oxocarbenium ion, but also alkyl or aryl ketals. Therefore, 
in addition to structure 115 we also proposed to study the mixed acetals and ketals 120 - 123 
as shown in Figure 6. 
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Figure 6. Additional targets for a sacrificial protecting group investigation. 
 
2.1. Synthesis of Donors 
 
2.1.1. Galactoside Donor  
 
 
Our study required the synthesis of a partially protected glycoside donor, ideally a 
3,4,6-tri-O-benzyl 2-hydroxy pyranoside, equipped with an anomeric leaving group. We 
initially decided that the most appropriate leaving group to prove our theory was that of a 
phenyl thioglycoside, as mentioned in Section 1.1.3 and also that we would target two separate 
donors based on galactose and mannose respectively. Scheme 78 outlines our approach to the 
former of these two targets starting with -D-galactopyranoside (124) which was acylated 
under standard conditions to give penta-acetate 125.  
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Scheme 78. Initial stages of galactoside donor synthesis. 
a) Ac2O, H2SO4, r.t., 16 hrs. b) HSR, SnCl4, DCM, 0 
oC – r.t., 12 hrs. c) MeOH, NaOMe, 0 oC 
– r.t., 36 hrs. (83) (84) (85) (86) 
 
 Acylation proved relatively straightforward and follows a nucleophilic acyl 
substitution mechanism as outlined in Scheme 79. 
 
 
Scheme 79. Acylation of a hydroxide functional group. 
  
 The reaction is initiated by protonation of the carbonyl oxygen which renders the 
carbonyl group more susceptible to nucleophilic attack from the hydroxyl function. Proton 
transfer and regeneration of the acid catalyst then furnish the acylated product 125 which was 
purified by recrystallization. With the penta-acetate in hand we turned our attention to preparing 
the thioacetal which would be our donor in future coupling studies. Reaction of acetate 125 
with thiophenol in the presence of tin (IV) chloride gave crude thioglycoside 126a following 
the mechanistic pathway outlined in Scheme 80. 
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Scheme 80. Thioglycoside synthesis from the anomeric acetate. 
 
 Problems arose however when we attempted to purify 126a since it co-eluted with the 
starting material when subjected to flash column chromatography. Attempts to solve this 
problem by utilising different column solvents or fractional recrystallisation proved 
unsuccessful so we decided to take the crude mixture and subject it to basic hydrolysis to give 
thioglycoside 127a along with D-galactose (124). Unfortunately, we were still unable to effect 
purification and so we switched our attention to preparing the ethyl thioglycoside 127b. 
Therefore, reaction of acetate 125 with ethanethiol, again using tin (IV) chloride, proceeded 
smoothly to give, after chromatography, ethyl thioglycoside 126b in excellent yields. This 
tetra-acetate was then hydrolysed with a catalytic amount of sodium methoxide in methanol 
to give tetrol 127b. 
 
Scheme 81 now outlines the next stage in our synthesis to achieve a glycoside housed 
with a set of complementary protective groups. We began our synthesis with the 
chemoselective protection of the primary hydroxyl function using TBDPS chloride to give 
silyl protected monosaccharide 128 in an acceptable, though disappointing, yield of 62%. We 
then used the fact that the triol in 128 was arrayed to give both a 1,2 trans and a 1,2 cis diol 
embedded in the trihydroxy system which allowed the selective protection of the 3,4 (cis) diol 
as its acetonide to give the alcohol 129. 
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Scheme 81. Protective group manipulations on ethylthio galactose. 
a) TBDPSCl, DMAP, DMF, r.t. – 40 oC, 36 hrs. b) Acetone, 2,2-Dimethoxy Propane, 
Camphorsulfonic acid, r.t., 2 hrs. (87) (88) (89). 
 
It is interesting to note the relatively poor yield of the silylation of 127b to produce 
triol 128 when these reactions usually proceed in high if not quantitative yields. Scheme 82 
below shows the accepted mechanism for silylation of a primary hydroxyl group with TBDPS 
chloride. 
 
Scheme 82. Mechanism of the silyl ether formation. 
 
 Activation of the silyl protective group is achieved with DMAP to produce a salt-like 
intermediate. This sterically bulky substrate can only be approached by the less hindered 
primary alcohol of tetrol 127b which, after deprotonation with triethyl amine gives protected 
species 128. Our problems arose due to the insolubility of the starting material in DMF which 
meant that reaction proceeded at a prohibitively slow rate. On warming the reaction mixture 
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to 40 oC we found that dissolution of the starting material was facilitated and reaction was 
initiated. However, at these elevated temperatures, we found that protection of the C-4 
hydroxyl group was a significant by product and we were therefore forced to monitor the 
reaction closely by tlc and accept a compromise yield where we quenched the reaction before 
full consumption of the starting material had ocurred. Fortunately acetonide formation 
proceeded with no such issues to produce alcohol 129 as shown below (Scheme 83). In this 
instance the reaction is under thermodynamic control as opposed to the kinetics of silylation 
from the previous scheme. Scheme 83 shows the reaction of triol 128 with oxonium species 
130 to give mixed acetal 131. It should be noted that acetal formation at all three hydroxyl 
groups is possible but for reasons of simplicity only the reaction at C-3 is shown. 
 
 
Scheme 83. Formation of the isopropylidene ketal. 
 
 Mixed acetal 131 can then cyclise to give both the trans and cis fused bicyclic systems, 
however since the trans fused acetonide 129 is the more thermodynamically stable, it is the 
sole product of the reaction. Finally we required to protect the remaining hydroxyl of structure 
129, preferably with a protecting group that would be complementary to both the silyl and 
ketal protecting groups already in place. Our initial thought was to make the para-
methoxybenzyl ether which is easily cleaved with DDQ to regenerate the alcohol. However 
the PMB chloride proved a difficult reagent to purify, and maintain in a pure state, due to its 
propensity to undergo ‘self-alkylation’. We turned our attention instead to the use of allyl 
bromide and effected a synthesis of fully protected monosaccharide 132 by treatment of 
alcohol 129 with sodium hydride and allyl bromide in DMF under standard conditions 
(Scheme 84). 
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Scheme 84. Allylation of a secondary alcohol. 
 
 Although monosaccharide 132 was not our final target in terms of achieving a benzyl 
protected 2-hydroxyglycosyl donor, the protective group array in place meant that we could 
access our target easily. We therefore decided to turn our attention to the synthesis of a mannose 
analogue which would provide us with a second model for our neighbouring group directed 
glycosylation study.  
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2.1.2. Ortho-ester 
 
 Scheme 85 shows the initial steps in our synthetic approach beginning with -D-
mannopyranoside (133) which was acylated under standard conditions to give the penta-
acetate 134. Reaction of the acetate with hydrogen bromide in acetic acid then gave bromo 
sugar 135 which almost immediately began to cause problems for us. 
 
 
Scheme 85. Synthesis of acetyl bromo mannoside. 
a) Ac2O, H2SO4, r.t., 24 hrs. b) HBr, AcOH, DCM, r.t., 24 hrs. 
14 
 
 The bromosugar proved to be extremely unstable and we therefore used it in the next 
step of our synthesis without additional purification. Thus crude bromosugar 135 was treated 
with methanol in the presence of 2,6-lutidine and tetrabutyl ammonium bromide to give ortho 
ester 136 as shown in Scheme 86. (90) (91). 
 
 
Scheme 86. Synthesis of orthoester. 
a) MeOH, 2,6 lutidine, Bu4NBr, r.t., 36 hrs.  
 
 However, all attempts to purify this compound proved futile and the major product 
from the reaction appeared to be the methyl mannoside 137 produced from migration of the 
methoxy to the anomeric position. Rather than abandon this approach, we considered that we 
may be able to use this unexpected rearrangement to our advantage in a shorter synthesis of a 
2-hydroxy donor. Using commercially available acetyl bromo galactoside (138) as our model 
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we treated the bromide with pentenyl alcohol under conditions for ortho ester formation as 
shown in Scheme 87. (90) (91).  
 
 
 
Scheme 87. Formation of the n-pentenyl ortho-ester. 
a) 4-Penten-1-ol, 2,6-lutidine, Bu4NBr, r.t., 36 hrs.  
 
 Again, however, we encountered problems with isolating and manipulating ortho ester 
139 and, despite spectral data indicating we had synthesised the target compound (Figure 7), 
we were forced to abandon this approach to our donor because of the reactions inconsistency. 
The characteristic signal corresponding to the methyl substituent of the ortho-ester (M01 from 
Figure 7) is observed at around 1.5ppm - the integration is close but not perfect because the 
NMR shown is of the crude reaction mixture. 
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Figure 7. 3,4,6-tri-O-acetyl-1,2-O-(1-methoxyethylidene)-α-D-glucopyranose H1 NMR. 
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2.1.3. Glucal and n-Pentenyl Glycoside 
 
 At this stage we decided to re-evaluate our strategy towards our model donor 
systems. Whilst synthesis of the galactoside donor had been successful it would require a ten 
step synthetic sequence to gain the monosaccharide with the desired protecting group array 
which could make multigram production difficult. In addition, our synthesis of a mannoside 
donor was curtailed as it was plagued by capricious reactions. We therefore looked for a new 
and more succinct route to a 2-hydroxy donor system and found that Kiessling had recently 
published a short route from commercially available D-glucal (140) as shown below in 
Scheme 88 (92). 
 
 
Scheme 88. Synthesis from the corresponding glycal. 
a) BnBr, NaH, n-Bu4NI, DMF, 0 
oC - r.t., 24 hrs. b) OsO4, NMO, Acetone, H2O, r.t., 24 hrs. 
(92) c) Ac2O, H2SO4, 0 
oC - r.t., 24 hrs. d) HSEt, Sn(IV)Cl4, DCM, 0 
oC - r.t. 48 hrs. e) MeOH, 
MeONa, 0 oC, 5 hrs 
 
Thus we took D-glucal (140) and subjected it to standard benzylation conditions to give 
fully benzylated glucal 141 which was then dihydroxylated using osmium tetroxide and N-
methyl morpholine-N-oxide as co-oxidant to give diol 142 in an excellent yield of 90%. We 
were delighted to observe that the reaction was almost completely stereoselective, producing 
the glucose configuration by approach of the osmium tetroxide to the bottom face of the double 
bond (Scheme 89). The mechanism for dihydroxylation is well established and, despite some 
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speculation, the key step is accepted as being a (3+2) cycloaddition of the osmium tetroxide to 
the double bond to give osmate ester 146. Presumably, in this case, the bottom, convex face of 
the double bond is far more accessible than the top face and, in addition, the anomeric effect 
may also contribute to stabilising the transition state (and product) of the reaction which would 
account for the high selectivity (93)  (94)  (93). 
 
 
Scheme 89. Mechanism of osmium tetroxide oxidation with N-methyl morpholine N-oxide. 
 
Hydrolysis of the intermediate osmate ester produces the diol as well as osmium trioxide 
which is reoxidised by NMO back to the tetroxide. 
The next step in the synthetic sequence involved acylation of the diol 142 to give the 
diester 143 which in turn was reacted with ethane thiol in the presence of the Lewis acid tin 
(IV) chloride to give the thioglycoside. Finally, hydrolysis of the acetate gave 2-hydroxy donor 
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144 in only five steps from D-glucal. Not only was this synthesis particularly efficient in 
comparison to our previous two attempts, but all the reactions proved to be both high yielding 
and reproducible, making it possible to access multigram quantities of donor for model coupling 
studies. 
Spurred on by the success of our synthesis of the thioglycoside donor we decided to 
investigate whether this same route could also be used to make an n-pentenyl glycoside. This 
would provide us with two model systems based on significantly different anomeric activators 
which in turn increased the chances of success in developing our sacrificial protective group 
methodology. Acetate 143 was therefore reacted with pentenyl alcohol, again in the presence 
of tin (IV) chloride to give n-pentenyl glycoside 146 which was in turn subjected to basic 
hydrolysis of the remaining ester function to give the analogous 2-hydroxy pentenyl donor 
147 (Scheme 90). 
 
 
Scheme 90. N-pentenyl glycoside donor 
a) 4-penten-1-ol, Sn(IV)Cl4, DCM, 0 
oC - r.t. 48 hrs. e) MeOH, MeONa, 0 oC, 5 hrs. 
 
 Interestingly displacement of the anomeric acetate with pentenyl alcohol did not 
proceed as smoothly as with ethane thiol, presumably due to a competing reaction in which 
the alcohol reacted with the tin reagent via displacement of the chloride. However, we were 
able to develop conditions based on high dilution, slow addition of the tin reagent and multiple 
small scale reactions that gave us an acceptable yield for the glycosylation. In addition, the 
selectivity for the conversion of 143 to 146 favoured formation of the  anomer (Scheme 90 
shows only the α anomer). On deacylation of the ester to yield alcohol 147 we observed that 
the RF of the α and β isomers were significantly different, so much so that the anomers were 
readily separable by column chromatography. In later repetitions of the reactions we found it 
was also purifiable by recrystallization. The structure of 147 was confirmed by spectroscopic 
analysis, however the resulting -anomer was found to be a solid from which we were able to 
grow crystals of sufficient quality for X-ray crystallography. The resulting X-ray crystal 
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structure (figure 8) was obtained which confirmed that we had synthesised the glucose donor 
target 147. 
 
Figure 8. X-ray crystal structure of 147( 
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2.2. Synthesis of Acceptors 
 
With the completion of our two donor systems we turned our attention to the synthesis 
of a series of glycosyl acceptors. Figure 8 shows our three choices based on testing the 
complementary nature of the sacrificial protecting group methodology with functionality 
commonly encountered in complex carbohydrate syntheses. Diacetone galactose (148) 
represents an easily accessible acceptor with a reactive primary hydroxyl group. However, the 
two acetonide protective groups are acid labile and so we will use this particular acceptor to 
ensure our methodology is compatible with acid sensitive functionality. Acceptor 18 is also a 
primary alcohol but the remaining hydroxyl groups are protected as ‘permanent’ benzyl ethers 
which are commonly used in oligosaccharide synthesis. Finally, monosaccharide 149 also 
represents a structure with a protective group array featuring only benzyl groups. However, in 
this case the acceptor is a 4-hydroxy glucopyranoside which represents one of the more 
difficult glycoside bonds to synthesise in carbohydrate chemistry and will therefore tests the 
limits of reactivity in our glycosylation methodology. (90) (95) (96). 
 
 
Figure 8. Glycoside acceptors. 
  
We began our study of the glycosyl acceptors with an approach to diacetone galactose 
(148) as shown below in Scheme 91. This was essentially a one-step synthesis involving the 
ketalisation of D-galactose (124) with acetone and 2,2-dimethoxypropane under acidic 
conditions to give the title compound in an excellent yield of 90%. 
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Scheme 91. Synthesis of diacetone galactose. 
 
As with the synthesis of acetonide 129 (vide supra) the reaction is performed under 
thermodynamic control. However, unlike that reaction outlined in Scheme 83 the reaction 
shown above has multiple outcomes based on the fact that different diol arrangements could 
be protected or the monosaccharide could undergo reaction through the furanose form. It is 
worth noting therefore that only one product was isolated from the reaction mixture in 
excellent yield and also that purification of the reaction residue could be achieved simply by 
filtration through a silica plug. 
 
With our first acceptor in hand we turned our attention to the synthesis of the other 
primary hydroxyl acceptor 18. Scheme 92 shows our three stage sequence to the 
monosaccharide starting from commercially available methyl -D-glucopyranoside (2). 
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Scheme 92. Synthesis of 1-O-methyl 2,3,4 tri-O-benzyl glucose acceptor 
a) TBDPSCl, Et3N, DMAP, DMF, 40 
oC, 48 hrs. b) BnBr, NaH, DMF, 0 oC - r.t, 24 hrs. c) 
TBAF, THF, r.t., 2 hrs. (85) (86) (95)  . 
 
Silylation of the primary hydroxyl group in 2 gave silyl ether 149 using similar reaction 
conditions to those outlined in Scheme 81. Benzylation of the three remaining hydroxyl groups 
in 149, again under standard reaction conditions, gave monosaccharide 150 which was treated 
with tetrabutyl ammonium fluoride to effect selective desilylation and afford acceptor 18 in 
excellent overall yield. (85) (86) (95)  (97). 
 
The synthesis of our final acceptor 149 was slightly more complex, involving a four 
step strategy and utilising some interesting protecting group methodology. Again our starting 
material was methyl glucopyranoside (2) which was converted to the 4,6 O-benzylidene acetal 
151 by reaction with benzaldehyde and its dimethyl acetal under acidic conditions. The 
reaction is again carried out under thermodynamic control but these conditions favour 
protection of a 1,3 diol over that of a 1,2 as the monosubstituent can now be placed in the 
equatorial position to produce, in this case, an almost strain free trans decalin system. The 
remaining two free hydroxyl groups were benzylated under standard conditions to give 
monosaccharide 152 and the benzylidene was then hydrolysed using aqueous acid to give the 
1,3 diol 153. Finally, we were able to selectively benzylate the primary alcohol in the 1,3 
system using tin acetal chemistry by initially reacting the diol with dibutyltin oxide to give the 
tin acetal intermediate 154 which on reaction with one equivalent of benzyl bromide produced 
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the 2,3,6 tribenzyl protected glycoside 149 (Scheme 93).  
 
 
 
Scheme 93. Synthesis of 1-O-methyl 2,3,6 tri-O-benzyl glucose acceptor. 
a) Benzaldehyde, benzaldehyde dimethyl acetal, TsOH, r.t., 48 hrs, b) BnBr, NaH, DMF, 0 oC 
- r.t., 24 hrs, c) AcOH, H2O, 80 
oC. d) Bu2SnO, Tol, (Dean-Stark), then TBAI, BnBr, DMF, r.t., 
16 hrs. (98) (96). 
 
Interestingly this final reaction was almost totally chemoselective yielding 
monosaccharide 149 with only a trace of acceptor 18 being produced as evidenced by tlc 
analysis of the reaction mixture. 
 
With both our model donor and acceptors now ready we were able to focus on 
developing our sacrificial protecting group methodology. 
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2.3. Sacrificial Protecting Group 
2.3.1. Glycosylation Control Reaction 
 
 Prior to our investigation into developing a sacrificial protective group we were 
conscious of the fact that we had not carried out a glycosylation procedure. Although we did 
not foresee any particular problem with the analysis of such reactions we nevertheless thought 
it would be advantageous to carry out a test coupling (Scheme 94). 
 
 
Scheme 94. Control reaction. 
 
Thus tetrabenzyl glucoside donor 17 was coupled with acceptor 18 using only NIS in 
DCM at room temperature overnight. The reaction gave disaccharide 19 in a yield of 68% as a 
mixture of anomers in a 2:1 ratio by analysing the peaks in the 1H NMR spectrum observed for 
the OMe group, as outlined in Figure 9. 
 
Figure 9. Isomaltose 1H NMR. 
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2.3.2. Pummerer Rearrangement 
 
 Our first approach to developing, and introducing, a sacrificial protecting group for the 
C-2 hydroxy function focussed on the use of the Pummerer rearrangement as outlined in 
Scheme 95. Sulfoxide 155 will react with acetic anhydride to give intermediate 156 which will 
immediately rearrange to give sulfonium ion 157. In the absence of water, we would then 
expect that this sulfonium would react with an alcohol to give mixed thioacetal 158. 
 
 
Scheme 95. The Pummerer rearrangement. 
 
As we had generated an ethyl thioglycoside as our donor (see structure 145) we 
reasoned we also needed to install a similar thioacetal functionality as our sacrificial protecting 
group at C-2. Our synthesis therefore began with the reaction of ethane thiol with benzyl 
bromide under basic conditions to give thioether 159 (Scheme 96). Having obtained the 
thioether in sufficient quantities we had two options for further functionalization. Our first 
approach was to chlorinate the benzylic position of the thioether to give the chloro thioether 
160 according to literature reports. Reaction of the thioether with N-chlorosuccinimide was 
carried out in carbon tetrachloride in accordance with previously reported conditions and 
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appeared to proceed smoothly. The literature stated that reaction was complete when the N-
chlorosuccinimide was consumed and was converted to succinimide which floated on the 
solvent (99) (as opposed to NCS which sank to the bottom of the reaction) which corresponded 
to our own observations. However, attempts to either isolate the chloro species or trap it in 
situ with a secondary alcohol lead to intractable mixtures and we quickly abandoned this 
approach. Instead we proceeded with our original intention to introduce the thioketal via a 
classical Pummerer rearrangement.  
 
 
Scheme 96. Studies on the Pummerer reactions. 
a) HSEt, DMAP, lutidine 30 min, 0 oC. b) CCl4, NCS, r.t., 2 hrs. c) KIO4 (aq), 0 
oC, 3 hrs. d) 
TFAA, DCM, 0 oC, 30 min, then cyclohexanol, 0 oC – r.t., 2 hrs.  (100) (101) (102) 
 
Thus oxidation of thioether 159 with aqueous sodium periodate gave the sulfoxide 
which was treated sequentially with trifluoroacetic anhydride, presumably to give intermediate 
161, and cyclohexanol. Unfortunately, we again could not isolate any thioacetal and despite 
an intensive investigation, including studying the reaction by NMR, we were unable to 
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develop suitable conditions to achieve our goal. It turned out that the Pummerer reaction was 
not as selective as we had originally hoped for and that rearrangement of an intermediate 
acylated sulfoxide such as that represented by structure 162 in Scheme 97 will undergo 
rearrangement to give both regioisomeric sulfonium ions. Given that both of these sulfonium 
ions can also produce two stereoisomeric products it is not surprising that we encountered 
difficulty in executing this reaction.  
 
 
Scheme 97. Regioselectivity in the Pummerer rearrangement. 
 
We were keen therefore not to dismiss the Pummerer reaction as a route to thioacetals 
and decided to investigate the reaction using the symmetrical dibenzyl sulphide. 
Unfortunately, similar, complex reaction mixtures were encountered and we decided to 
reconsider our approach. 
 
Procter has recently introduced a ‘connective Pummerer’ reaction which bypasses the 
necessity for either sulphide oxidation or rearrangement as outlined in Scheme 98. The reaction 
involves initial nucleophilic addition of a thiol, in this case protected cysteine 163 to a reactive 
aldehyde 164 to give hemi thioacetal 165. This thioacetal is then trapped with trifluoroacetic 
anhydride to give the Pummerer type adduct 166 which on treatment with Lewis acid gives 
the intermediate sulphonium ion 167 which will immediately cyclise to give the heterocycle 
168. 
 
We were conscious of two factors when attempting to apply this methodology, firstly 
that Procter had stated that a reactive aldehyde was required in the initial coupling with the 
thiol and also that all examples of the connective Pummerer to date had involved an 
intramolecular carbo-cyclisation. 
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Scheme 98. Procter’s connective Pummerer rearrangement (99). 
a) DCM, r.t., 24 hrs., b) TFAA, DCM, r.t., 2 hrs., c) BF3∙OEt, DCM, r.t., 2 hrs. 
 
Nevertheless, we were keen to try to apply Procter’s chemistry to the solution of our 
own problem associated with the generation of a thioacetal. Thus we mixed benzyl mercaptan 
with benzaldehyde in dichloromethane and allowed the mixture to equilibrate for 24 hours in 
an attempt to generate adduct 169. To this was added trifluoroacetic anhydride and the reaction 
mixture was stirred for an additional two hours in accordance with literature procedures before 
finally we added cyclohexanol and a Lewis acid in an attempt to generate thioacetal 170 
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(Scheme 99). 
 
 
Scheme 99. Application of the Procter protocol to the Pummerer rearrangement. 
a) DCM, r.t., 24 hrs., b) TFAA, DCM, r.t., 2 hrs., c) BF3∙OEt, DCM, ROH, r.t., 2 hrs. 
 
TLC monitoring of the reaction was hopeful as starting material had been consumed, 
however all attempts at isolating thioacetal 170 proved fruitless. Again we studied the reaction 
using nmr analysis but we were unable to confirm anything other than trace amounts of our 
target in the reaction mixture. It may be that the thioacetals we were attempting to prepare 
were extremely labile, especially under the conditions we were using, and that hydrolysis was 
a reaction that was competing with our attempts to trap the sulfonium ion with an alcohol. 
Clearly further investigation of these reactions is needed but unfortunately, with time pressing, 
we decided to move on in search of a more facile route. 
 
2.3.3. Para Methoxy Benzyl and Methyl Naphthyl 
  
 The difficulties we encountered in trying to develop a Pummerer rearrangement in 
addition to the dearth of literature precedent on the synthesis of acyclic thioacetals lead us to 
reconsider our approach to a sacrificial protective group.  
 
As outlined in Scheme 75 Ogawa has developed an intramolecular aglycone delivery 
system based on a para-methoxybenzylidine mixed acetal system. We reasoned that this 
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methodology could be adapted to our neighbouring group direction initially by targeting the 
synthesis of n-pentenyl-PMB ether (171) as shown below in Scheme 100. 
 
 
Scheme 100. Synthesis of PMB-n-pentenyl ether. 
 
Alkylation of n-pentenyl alcohol with PMB chloride under basic conditions thus gave 
ether 171 in excellent yield. Unfortunately, our attempts to carry out an oxidative coupling of 
ether 171 with our donor 147 to produce mixed acetal 172 met with failure and we instead 
isolated the starting monosaccharide along with para-methoxybenzaldehyde (173) from the 
reaction mixture (Scheme 101). 
 
 
Scheme 101. Attempted synthesis of a mixed acetal 
 
The isolation of para-methoxybenzaldehyde was at least a positive outcome from the 
reaction in that it suggested either that the oxonium ion from 171 had been formed or possibly 
we had indeed made mixed acetal 172 but it had hydrolysed. This latter result would have 
been in keeping with Ogawa’s own observations that mixed PMB acetals of this type were 
hydrolytically unstable. We decided therefore to adopt a compromise approach to acetal 172 
as shown in Scheme 102 in which we attempted a two stage synthesis of our donor system. As 
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shown below we first reacted monosaccharide 147 with PMB chloride under basic conditions 
to give the fully protected donor 174. This precursor was then treated with DDQ and excess 
pentenyl alcohol in the presence of molecular sieves to try and prevent water entering the 
reaction mixture and hydrolysing the product in situ. 
 
 
Scheme 102. Alternative synthesis of a mixed acetal. 
a) NaH, DMF, PMBCl, r.t. b) DDQ, 4-Penten-1-ol, 4 A mol sieves, DCM, r.t. 
 
Unfortunately, we were still unable to isolate the mixed acetal 172 with our reaction 
mixtures essentially consisting of the recovered monosaccharide 147 and para-
methoxbenzaldehyde. Multiple attempts at optimising the conditions such as basic work-up to 
avoid any acid contact and purification of the residue on both triethylamine doped silica gel 
and basic alumina proved fruitless. Our most successful attempt involved the use of the 
polymer-supported aldehyde scavenger PEG phenylethylenediamine in a bid to remove the p-
methoxybenzaldehyde impurity. This resulted in the isolation of trace amounts of the target 
mixed acetal 172 as can be seen in the 1H NMR spectrum of the reaction in figure 10. Even in 
this instance hydrolysis was occurring over the time of the 1H NMR experiment and the 1H 
NMR spectrum appears to be a mixture of the desired acetal along with substantial amounts 
of aldehyde formed via hydrolysis. 
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Figure 10. Crude iH NMR spectrum of our target donor 172. 
 
We were now beginning to understand the nature of our target donors and their inherent 
reactivity and it seemed to us that it wasn’t necessarily the chemistry that was causing us the 
difficulty but rather the lability of our target acyclic acetal (or thioacetal). As mentioned in 
Scheme 77 our strategy was based on kinetics, wherein, for a successful glycosylation strategy, 
we needed to generate the exocyclic oxonium ion before its cyclic counterpart. In designing 
our sacrificial protective group, we had perhaps chosen a system that was too reactive and 
therefore also highly acid labile. 
 
A review of the literature at this point indicated that we may also be able to use the 
naphthyl group in place of the p-methoxybenzyl which we considered might offer more 
stability to the mixed acetal. Thus, as shown below in Scheme 103, we again took 
monosaccharide 147 and introduced the 2-naphthyl protective group, under standard 
benzylation conditions, to give the fully protected system 175. An attempted mixed acetal 
formation using pentenyl alcohol and molecular sieves to minimise hydrolysis in conjunction 
2. Results and Discussion   
 118 
with the use of a polymer supported aldehyde scavenger unfortunately still failed to produce 
the desired mixed acetal. Repeated attempts to optimise the reaction conditions, as well as 
studying the reaction by nmr spectroscopy, did indicate that we were able to form the mixed 
acetal 176 but that it was still an extremely labile functional group and proved impossible for 
us to isolate. 
 
 
Scheme 103. Approach to naphthyl-pentenyl mixed acetal. 
a) NaH, DMF, 2-naphthyl bromide, r.t. b) DDQ, 4-Penten-1-ol, 4 A mol sieves, DCM, r.t. 
 
Despite the results from the study of the naphthyl protected sugar, it did appear that the 
naphthyl based mixed acetal may be slightly more acid stable than its PMB counterpart. Our 
supply of pentenyl donor 147 was regarded as a precious commodity and we did not want to 
use too much in a model study of acetal formation. However, we reasoned that the acetal could 
also be placed on the free hydroxyl of an acceptor where it could still be used as a sacrificial 
protective group in an asymmetric glycosylation. This convinced us to try a further study using 
acceptor 148 as the precursor to a mixed acetal as shown below in Scheme 104. 
 
  
Scheme 104. Approach to a mixed acetal for a 'reversed' neighbouring group direction. 
a) NaH, DMF, 2-naphthyl bromide, r.t. b) DDQ, 4-Penten-1-ol, 4 A mol sieves, DCM, r.t. 
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 Again, introduction of the naphthyl protecting group was straightforward giving 
monosaccharide 177 in high yield and multigram quantities. However, once again, after making 
several attempts to generate mixed acetal 178, we met the same problem of the aldehyde and 
alcohols. Deciding we this would be again unsuccessful we were faced with rethinking our 
approach. 
 
2.3.4. Iso Propylidene 
  
 Our attempts at forming both a mixed thioacetal or a mixed acetal had so far been 
thwarted, which we considered was associated with the lability of the functional group we 
were targeting. We returned to the literature and to perhaps the earliest example of 
intramolecular aglycone delivery with Hindsgaul’s use of an iso-propylidene tether to deliver 
a stereocontrolled glycosylation. The use of a dimethyl ketal as a sacrificial protective group 
should certainly cause less problems than the corresponding PMB or napthyl acetals and so 
we began a synthesis of a 2-alkoxypropene which would act as a standard hydroxyl protecting 
group. Scheme 105 outlines our approach from pentenyl alcohol which was acylated under 
standard conditions to produce ester 179.  
 
 
 
Scheme 105. Attempted synthesis of 2-Pentenyloxypropene. 
a) Ac2O, Pyridine, r.t. b) Tebbe reagent, THF, Pyridine, -78 
oC. 
 
We next attempted to methylenate the carbonyl in ester 179 with Tebbe’s reagent according 
to the literature. Unfortunately, the notoriously difficult Tebbe reaction to generate an enol 
ether proved our downfall and we were unable, despite repeated attempts, to isolate 2-
pentenyloxypropene (180). This also proved to be our last attempt at developing a sacrificial 
protective group as time constraints meant that we had to stop the investigation.  (103) (74) 
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2.4. Conclusion. 
 
 Although our ultimate goal of developing a novel, neighbouring group direction 
approach to asymmetric glycosylation was, unfortunately, unsuccessful. We did however 
optimise some efficient syntheses of both donor and acceptor molecules as shown in Figure 10 
below. 
 
 
Figure 10. Monosaccharide building blocks. 
 
Perhaps more importantly we gained valuable insight into the nature of mixed, acyclic 
acetals and thioacetals and their inherent susceptibility to hydrolysis. Our original premise, as 
laid out in Scheme 77, relies on the kinetics of oxonium ion formation and the fact that we 
should be able to generate oxonium ion 116 faster than the corresponding cyclic species 118. 
This should allow us to initiate a reaction cascade that ultimately leads to stereocontrolled 
glycosylation to deliver a cis 1,2 glycoside. 
 
There is a wealth of literature detailing the formation and hydrolysis of cyclic acetals, 
as well as numerous studies on glycosylation reactions, which gives a keen insight into both 
their reactivity. Surprisingly however there is relatively limited amount of data concerning 
acyclic acetals and our major source was that of previous work concerning intramolecular 
aglycone delivery. We had mistakenly begun the design of our sacrificial protecting group with 
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the assumption that a cyclic, secondary oxonium ion of type 118 would show similar stability 
to an acyclic counterpart. The target for our studies on ‘neighbouring group directed’ 
glycosylation therefore became monosaccharides with the type of structure represented in 172 
as shown in Figure 11. Our reasoning here was that we needed to generate a benzylic oxonium 
ion in order to ensure that the acyclic oxonium was formed before the cyclic form. 
 
 
 
Figure 11. Target donor equipped with sacrificial protecting group. 
 
It now seems obvious that we were overcautious in our approach to developing this 
piece of methodology and the problems that plagued our attempts to synthesis a mixed acetal 
were related to its lability. Fraser-Reid’s seminal work on the armed-disarmed effect gives a 
clear indication of the reactivity of glycosyl donors, indeed a monosaccharide with similar 
reactivity to one of our own building blocks was the subject of a kinetic study as shown below 
in Scheme 106. 
 
 
 
Scheme 106. Hydrolysis of a disarmed donor. 
 
 The slow reaction is a consequence of the benzylidene acetal protective group which 
hinders the donor from adopting a half-chair conformation necessary to accommodate the 
trigonal planar oxonium ion. It would therefore seem logical to propose a series of protecting 
groups with the structures outlined below in Figure 12. These structures should be much more 
accessible and would make for a relatively straightforward study, not only asymmetric 
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glycosylation but also on oxonium ion stability (104). Unfortunately, (and somewhat 
annoyingly), as can be seen from the figure, one of the structures corresponds to our final target 
enol ether 180 which we were in the process of synthesising before we ran out of time. 
 
 
 
Figure 12. A series of protecting groups for a NGD glycosylation study (104). 
 
 Thus as an initial piece of future work we are proposing, as briefly outlined below in 
Scheme 107, a study of the glycosylation of donor 181 with an acceptor such as 18 to give 
disaccharide 182. It would also seem logical (especially with the benefit of hindsight) to 
perform a computational model of the oxonium ions generated in the reaction, represented by 
intermediate 183, to calculate the relative energies of the cyclic and acyclic components and 
therefore aid in the rational design of a sacrificial protective group. 
 
Scheme 107. Future work. 
 
We hope that this work will be carried out in the near future and contribute to the 
development of a novel methodology for stereocontrolled glycosylation. 
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General Procedures: 
 
 All the reactions were performed from oven dried glassware and metal ware. The 
solvents where dried from clean activated molecular sieves for 14 – 16 hours before hand. 
Solvents where necessary, silica and other reagents/reactants were ordered as >98% pure from 
either Sigma-Aldrich, Fisher Scientific, Alfa Aesar, Acros Organics or TCI Chemicals. 
Solvent evaporation was performed under Büchi Rotor Vap vacuum stills. Distillation 
processes were performed under high vacuum through a quick fit – assembled vacuum still 
from oven dried clean glassware. NMR analysis was obtained from a JEOL Delta2 Nuclear 
magnetic resonance spectrometer or a Bruker 300 Nuclear magnetic spectrometer. TLC used 
Fisher scientific brand Silica – glass plates. Flash column chromatography was performed via 
direct application of the compound, as a concentrated solution onto the column. The solid 
phase was prepared off column as a silica gel slurry, made with the mobile phase determined 
from TLC analysis. All reactions that involved heating where warmed under a condenser, and 
the reactions that involved stirring where stirred at a steady rate with a magnetic stirrer bar. 
All procedures were carried out under a nitrogen atmosphere where necessary. Procedures that 
occurred under this project were supervised and cautions of substances hazardous to health 
(COSHH) where taken with compliance to HR safety regulations. 
 
Penta-O-Acyl D-Galactopyranoside 125 
 
D-galactose (20.58 g, 0.114 mol) was mixed with acetic anhydride (125 mL, 1.13 mol, 9.9 
eqv.) at rt. H2SO4 (3 drops, <0.1 mmol) was added, and the reaction was stirred for 16 h. The 
reaction was then diluted with EtOAc (200 mL) and quenched with saturated NaHCO3 (200 
mL) and extracted twice with EtOAc (2 × 200 mL). The combine organic phases were washed 
twice with water (2 x 200 mL) and once with brine (200 mL). The organic phase was dried 
with MgSO4 and concentrated to afford a crude yellow oil. The residue was purified via silica 
gel chromatography using a 10% – 100% EtOAc in hexanes gradient to afford pentaacetate 
125 as white crystals (42.6 g, 96%, α:β ~6:1). 1H NMR (CDCl3, 400 MHz) δ 6.14 (d 0.86H, 
C1H (α)), 5.69 (d, 0.14H, J = 8 Hz, C1H (β)), 5.41 (d, 1H, J = 4 Hz, C3H), 5.32 (dt, 1H, J = 
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4, 8 Hz, C4H), 4.18-4.02 (m, 3H, C5,6,4H), 3.89 (dd, 1H, J = 4, 4, C6H), 2.16 (s, 3H, Ac), 
2.11 (s, 3H, Ac), 2.04 (s, 6H, 2Ac), 1.98 (s, 3H, Ac). Literature 1H NMR (CDCl3, 400 MHz) 
δ 5.69 (d, 1H, J = 8.3 Hz), 5.42 (d, 1H, J = 3.0 Hz), 5.33 (dd, 1H, J = 10.4, 8.3 Hz), 5.07 (dd, 
1H, J = 10.4, 3.4 Hz), 4.14 (m, 2H), 4.05 (t, 1H, J = 6.6 Hz), 2.16 (s, 3H), 2.12 (s, 3H), 2.04 
(s, 6H), 1.99 (s, 3H) (105). 13C NMR (CDCl3, 100 MHz) δ 169.8, 169.7, 169.6, 169.3, 168.1, 
89, 68.2, 66.9, 66.8, 65.9, 60.7, 20. M.p. 141 – 142 oC. Specific Rotation [α]D20 +0.41 (1.8 
mg/mL in EtOH). max: 2990, 2917, 2162, 2030, 1746, 1737, 1373, 1211, 1041, 958, 901 cm-
1. 
 
Ethane 2,3,4,6 tetra-O-acyl D-thiogalactopyranoside 126b 
 
 
Pentaacetate 125 (12.31 g, 0.032 mol) was dissolved in 100 mL of DCM at 0 oC. HSEt (1.85, 
0.035 mol, 1.1 eqv.) and SnCl4 (2 mL, 0.001 mol as a 2 N solution in DCM) were added, the 
reaction was stirred and allowed to warm to r.t. The reaction was stirred for 4 days, and further 
SnCl4 (6 mL, 0.012 mol as a 2 N solution in DCM) was added every 24 h. The reaction was 
quenched with 1mol HCL (200 mL), and extracted with DCM (3 × 150 mL). The combined 
organic phases were then washed with water (2 x 150 mL) and brine (150 mL). It was then 
dried over MgSO4 and concentrated. The resulting yellow oil was purified via silica gel 
chromatography using a 10−100% EtOAc in hexanes gradient to afford thioglycoside 126b as 
a colourless oil, which later crystalised and formed a white solid (6.57g 62.6%, α:β = 1:6.3). 1H 
NMR (CDCl3, 400 MHz) δ 6.33 (d, 0.19H, J = 8 Hz, C1H (α)), 5.71 (d, 0.81H, J = 4 Hz, C1H 
(β)), 5.42-5.3 (m 1H, C3H), 4.61-456 (m, 2H, J = 4 Hz, C2,4H), 4.16-4.04 (m, 3H, C5,6H), 
2.61-2.45 (m, 2H, SEt CH2), 2.11 (s, 3H, Ac), 2.04 (s, 3H, Ac), 2.01 (s, 3H, Ac), 1.96 (s, 3H, 
Ac), 1.28-1.19 (m, 3H, SEt CH3), Literature 
1H NMR (CDCl3, 250 MHz): δ 5.36 (dd, 1H, J = 
3.3, 1.0 Hz), 5.17 (dd, 1H, J = 9.9, 9.8 Hz), 4.98 (dd, 1 H, J = 10.0, 3.3 Hz), 4.43 (d, 1H, J = 
9.8 Hz), 4.14-4.00 (m, 2H), 3.90-3.84 (m, 1H), 2.74-2.56 (m, 2H), 2.09 (s, 3H), 2.00 (s, 3H), 
1.98 (s, 3H), 1.92 (s, 3H), 1.28-1.19 (m, 3H, J = 7.4 Hz) (106). 13C NMR (CDCl3, 100 MHz) δ 
171.8, 170.7, 170.1, 76.8, 76.3, 75.6, 74.4, 72.7, 68.1, 62.8, 24.1, 21.1, 20.7, 18.4. M.p. 104 – 
105oC. Specific Rotation [α]D20 +0.28 (1.4 mg/mL in EtOH). max: 2972, 2871, 1750, 1741, 
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1446, 1368, 1225, 1211, 1117, 1079, 1049, 945, 912 cm-1. 
Peak assignment by H1 (COSY) NMR: 
 
 
Ethane D-thiogalactopyranoside 127b 
 
Thioglycoside 126b (6.45 g, 0.02 mol) was dissolved in 100 mL of Methanol at 0 oC. NaOMe 
(6.5 mL, 25% wt. solution in Methanol) was added and the reaction was stirred and allowed 
to warm to r.t. The reaction was stirred for 24 h. The reaction was quenched with ion exchange 
resin amberlite ir-120(H). The organic phase was then concentrated and dried under high 
vacuum. The resulting brown solid tetrol 127b which was taken onto the next stage without 
purification (5.26 g 117%). 
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Ethane 6-O-tert-butyldiphenylsilyl D-thiogalactopyranoside 128 
 
Tetrol 127b (5.7 g, 0.026 mol) was dissolved in 100 mL of DMF at r.t. Triethylamine (10 mL), 
dimethyl amino pyridine (6.5 g) and tert-butyl diphenyl silyl chloride (7.86 g, 0.0286 mol, 1.1 
eqv.) were added, the reaction was stirred for 24 h at room temperature. 3.5 g of TBDPSCl 
(approx. 0.5 eqv.) was added and it was heated to 40 oC and stirred for a further 4 days. Finally, 
it was heated to 77 oC and stirred for a final 6 hours before the reaction was cooled and quenched 
with water (100 mL), and extracted with Et2O (3 × 100 mL). The combined organic phases 
were then washed with water (2 x 150 mL) and brine (100 mL). It was then dried over MgSO4 
and concentrated. The resulting yellow oil was purified via silica gel chromatography using a 
50−100% EtOAc in hexanes gradient to afford silane 128 as a colourless oil (7.53 g 62%).  
1H NMR (CDCl3, 400 MHz) δ 7.72-7.66 (m 4H Ar), 7.45-7.35 (m 6H Ar), 5.42 (d, 1H, J = 5.6 
Hz, C1H), 4.24 (dd,1H, J = 6.4, 6.4 Hz, C3H), 4.19 (dd, 1H, J = 8, 5.2 Hz, C2H), 4.11 (d, 1H 
J = 5.28 Hz, C4H), 3.89-3.8 (m, 2H, C5,6H), 3.55 (dd, 1H J = 9.64, 4 Hz, C6H), 2.56 (dq, 2H 
J = 8 Hz SEt CH2), 1.26 (t, 3H J = 7.64 Hz SEt CH3), 1.04 (s, 9H, t-Bu). Literature 
1H NMR 
(CDCl3, 360 MHz) δ 7.65 (m, 4H), 7.40 (m, 6H), 5.42 (d, 1H, J = 5.5 H), 4.17 (dd, 1H, J = 5.5, 
5.5 Hz), 4.12 (dd, 1H, J = 9.9, 5.5 Hz), 4.11 (d, 1H, J = 3.3 Hz), 3.91 (dd, 1H, J = 10.7, 5.5 Hz), 
3.70 (dd, 1H, J = 10.7, 5.2 Hz), 3.54 (dd, 1H, J = 9.9, 3.3 Hz), 2.62 (dq, 1H, J = 7.4 Hz), 2.55 
(dq, 1H, J = 7.4 Hz), 1.26 (t, 3H, J = 7.4 Hz), 1.05 (s, 9H) (107). 13C NMR (CDCl3, 100 MHz) 
δ 132.8, 129.2, 127.2, 85.2, 84.7, 71, 63, 36, 31, 23.7, 23.3, 18.6. Specific Rotation [α]D20 +0.98 
(3 mg/mL in EtOH). max: 3372 (Broad), 2929, 2957, 2347, 2125, 2081, 1750, 1660, 1428, 
1387, 1256, 1140, 1094, 1059, 824 cm-1 
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Ethane 3,4 O-(1-methylethylidene) 6-O-tert-butyldiphenylsilyl D-
thiogalactopyranoside 129 
 
Silane 128 (7.45g, 0.026 mol) was dissolved in 100 mL of acetone at r.t. Dimethoxy propane 
(10 mL) and camphorsulfonic acid (1 g approx.) were added, the reaction was stirred for 16 h 
at room temperature. The reaction was quenched with saturated NaHCO3 (100 mL), and 
extracted with Et2O (3 × 100 mL). The combined organic phases were then washed with water 
(2 x 100 mL) and brine (100 mL). It was then dried over MgSO4 and concentrated. The 
resulting yellow oil was purified via silica gel chromatography using a 50% EtOAc in hexanes 
to afford acetonide 129 as a colourless oil (6.16 g 76.7%). 1H NMR (CDCl3, 400 MHz) δ 7.74-
7.68 (m, 4H Ar), 7.45-7.36 (m, 6H, Ar), 5.24 (d 1H, J = 5.12 Hz C1H), 4.38 (t 1H, J = 5.2 Hz, 
C3H), 4.19 (d 1H, J = 5.28 Hz C2H), 3.99 (d 1H, J = 2.16 Hz, C4H), 3.86 (d 1H, J = 2.64 Hz), 
3.85 (dd 2H, J = 8, 1.24 Hz), 3.8 (t 1H, J = 6.64 Hz), 2.59 (q 2H, J = 6.4Hz SEt CH2), 1.88 (s 
6H) 1.23 (t 3H J = 9.4 SEt CH3), 1.17 (s 6H, i-Pr 2Me) 1.07 (s 9H, t-Bu). Literature 
1H NMR: 
δ 7.72–7.38 (m, 10H, aromatic protons), 5.09 (t, 1H, J = 9.6 Hz, H-2), 4.35 (d, 1H, J ¼ 9.9 
Hz, H-1), 4.16 (d, 1H, J = 3.0 Hz, H-4), 3.95–3.91 (m, 2H, H-6), 3.62 (dd, 1H, J2,3 = 9.3 Hz, 
J3,4 = 3.2 Hz, H-3), 3.51 (t, 1H, J = 5.0 Hz, H-5), 2.68 (m, 2H, SCH2CH3), 2.15 (s, 3H, 
OCOCH3), 1.24 (t, 3H, J = 7.5 Hz, SCH2CH3), 1.06 (s, 9H, Ph2SiC(CH3)3) (108). 13C NMR 
(CDCl3, 100 MHz) δ 135.7, 133.3, 129.8, 127.78, 109.5, 84.1, 79.4, 77.7, 76.7, 73.7, 63, 28.4, 
26.9, 15. Specific Rotation [α]D20 +0.30 (4.9 mg/mL in EtOH). max: 3411 (Broad), 3071, 3060, 
2981, 2931, 2857, 2130, 2017, 1739, 1589, 1473, 1428, 1374, 1242, 1217, 1112, 1105, 1083, 
1046, 1008, 875 cm-1 
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Ethane 2-O-allyl 3,4 O-(1-methylethylidene) 6-O-tert-butyldiphenylsilyl D-
thiogalactopyranoside 132 
 
Acetanide 129 (2.18 g, 0.00435 mol) was dissolved in 25 mL of DMF at r.t. Allyl bromide 
(0.44 mL 0.0052 mol, 1.2 eqv.) and tetra-n-butyl ammonium iodide (1 eqv. approx.) were 
added and dissolved. This was cannulated onto NaH (0.24 g, 0.0061 mol, 1.4 eqv. 60% 
dispersal in mineral oil.) mixed with 5 mL of DMF at 0 oC. The reaction was stirred for 4 h 
and allowed to warm to room temperature. The reaction was quenched with water (50 mL), 
and extracted with Et2O (3 × 50 mL). The combined organic phases were then washed with 
water (2 x 50 mL) and brine (50 mL). It was then dried over MgSO4 and concentrated. The 
resulting yellow oil was purified via silica gel chromatography using a 20% EtOAc in hexanes 
to afford allyl ether 132 as a colourless oil (1.91 g 81.2%). 1H NMR (CDCl3, 400 MHz) δ 
7.73-7.66 (m 4H, Ar), 7.45-7.36 (m, 6H, Ar), 5.99-5.89 (m, 1H, Vinyl CH1), 5.58 (d, 1H, J = 
8 Hz, C1H), 5.33-5.23 (m, 2H, Allyl CH2), 4.46 (dd, 1H J = 8, 4.28 Hz, C3H), 4.29-4.11 (m 
4H, C2,4H, C2-CH2), 3.97-3.77 (m 3H, C5,6H), 2.61-2.52 (m 2H, SEt CH2), 1.25 (t 3H J = 
9.2 Hz, SEt CH3), 1.15 (s 6H, i-Pr 2Me) 0.97 (s 9H, t-Bu).
13C NMR (CDCl3, 100 MHz) δ 
135.8, 134.7, 130, 129.9, 129.6, 127.8, 117.9, 109.3, 84.9, 83.6, 78.2, 76.2, 73.4, 68.9, 63.1, 
28.1, 26.9, 23.7, 14.7. Specific Rotation [α]D20 +0.15 (0.5 mg/mL in EtOH). max: 3457 
(Broad), 3071 2956, 2930, 2857, 2212, 1749, 1589, 1472, 1425, 1380, 1243, 1218, 1106, 1047, 
998, 923, 875 cm-1 
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Ethane 2-O-allyl 3,4-O-(1-methylethylidene) D-thiogalactopyranoside 132b 
 
Allyl ether 132 (0.42 g, 0. 775 mmol, 1 eqv.) was dissolved in 15 mL THF at r.t. tetra-n-butyl 
ammonium fluoride (0.85 mmol, 1.1 eqv., 1 mol solution in THF) was added. The reaction 
was stirred for 4.5 h. The reaction was then concentrated under reduced pressure and diluted 
with 20 mL of EtOAc. The reaction was washed with water (20 mL) and extracted with EtOAc 
(3 × 20 mL). The combined organic phases were washed with water (2 x 20 mL) and brine 
(20 mL). It was then dried over MgSO4 and concentrated. The resulting off white oil was 
purified via silica gel chromatography using a 15% EtOAc in hexanes to afford Ethane 2-O-
allyl 3,4-O-(1-methylethylidene) D-thiogalactopyranoside 132b as a colourless oil (0.22 g, 
70.4%). 1H NMR (CDCl3, 400 MHz) δ 5.96-5.86 (m 1H), 5.38 (d 1H, J = 5.28 Hz), 5.25 (q 
2H, J = 9.72 Hz), 4.31 (dd 1H, J = 7, 3.44 Hz), 4.29-4.12 (d 4H), 3.96-3.91 (m 1H), 3.81-3.74 
(m 2H), 2.6-2.54 (m, 2H), (t 3H J = 3 Hz). 
 
2,3,4,6 tetraacetyl D-bromo galactopyranoside 138 
 
Acetate 125 (6.4 g, 0.016 mol) was dissolved in DCM (60 mL) in dry conditions, in a round 
bottomed flask equipped with a dropping funnel, and cooled to 0 oC. HBr in acetic acid 
solution (60 mL, 33% solution) was added into the dropping funnel, and proceeded to be added 
dropwise into the reaction medium over a period of 3 hours. The reaction was then allowed to 
warm to room temperature and left to stir for a further 16 hours. The reaction was then 
cautiously quenched with saturated sodium carbonate (100 mL) solution and transferred to a 
separating funnel. The aqueous phase was then extracted with DCM (3x50 mL). The combined 
organic phases where then washed with water (2x50 mL) and brine (50 mL), dried over 
magnesium sulphate and concentrated under vacuum. The residue was then purified by 
column chromatography to yield bromide 138 as an off white solid (3.7 g, 54.83%). 1H NMR 
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(CDCl3, 400 MHz) δ 6.62 (d 1H, J = 4 Hz, C1H), 5.43 (m, 1H, C3H), 5.3 (dd 1H, J = 10.7, 
3.4 Hz, C2H), 4.95 (dd 1H, J = 10.7, 4 Hz, C4H), 4.4 (t 1H, J = 6.4 Hz, C6H), 4.06 (m, 2H, 
C5,6H), 2.06 (s, 3H, Ac), 2.02 (s, 3H, Ac), 1.97 (s, 3H, Ac), 1.92 (s, 3H, Ac), Literature 1H 
NMR (CDCl3, 400 MHz) δ 6.69 (d 1H, J = 3.9 Hz), 5.51 (m, 1H), 5.39 (dd 1H, J = 10.6, 3.3 
Hz), 5.04 (dd, 1H, J = 10.6, 3.9 Hz), 4.48 (t 1H, J = 6.5 Hz), 4.18 (dd, 1H, J = 11.4, 6.4 Hz), 
4.09 (dd 1H, J = 11.4, 6.7 Hz), 2.14 (s, 3H), 2.10 (s, 3H), 2.05 (s, 3H), 2.00 (s, 3H) (105). 13C 
NMR (CDCl3, 100 MHz) δ 170.3, 170, 169.9, 169.8, 88.2, 71.1, 68, 67.8, 67, 60.9, 20.7, 20.6, 
20.6, 20.6. Specific Rotation [α]D20 +1.03 (0.8 mg/mL in EtOH,). max: 3448, 3428, 2978, 
2916, 2850, 2037, 1986, 1744, 1430, 1370, 1325, 1214, 1129, 1096, 1046, 1033, 846 cm-1. 
 
D-Glucal 140 
 
3,4,6-tri-O-acetyl glucal (2.24 g, 0.00823 mol) was dissolved in 25 mL of Methanol at 0 oC. 
NaOMe (2.5 mL, 25% wt. solution in Methanol) was added and the reaction was stirred and 
allowed to warm to r.t. The reaction was stirred for 16 h. The reaction was quenched with ion 
exchange resin amberlite ir-120(h). The organic phase was then concentrated and dried under 
high vacuum. The resulting brown solid glucal 140 was taken onto the next stage without 
purification (1.46 g, 122%). 
 
 
Tri-O-benzyl D-glucal 141 
 
Triol 140 (7.55 g, 0.0517 mol) was dissolved in 50 mL of DMF at 0 oC. Benzyl bromide (30 
mL 0.17 mol, 3.3 eqv.) and tetra-n-Butyl Ammonium Iodide (9.4 g) were added and dissolved. 
This was cannulated onto NaH (10.3g, 0.186mol, 3.6eqv. 60% dispersal in mineral oil.) mixed 
with 50ml of DMF at 0 oC. The reaction was stirred for 16 h and allowed to warm to room 
temperature. The reaction was quenched with water (150 mL), and extracted with Et2O (3 × 
200 mL). The combined organic phases were then washed with water (2 x 200 mL) and brine 
(200 mL). It was then dried over MgSO4 and concentrated. The resulting yellow oil was purified 
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via basic (5% triethylamine treated) silica gel chromatography using a 12% EtOAc in hexanes 
to afford benzyl ether 141 as a white crystal (11.62 g, 54%). M.p. 54-56 oC. 1H NMR (CDCl3, 
400 MHz) δ 7.39-7.25 (m 15H, Ar), 6.44 (dd 1H, J = 4.92, 1.28 Hz, C1H), 4.9-4.85 (m 1H, 
C3H), 4.69-4.57 (m 6H, Bn), 4.25-4.23 (m 1H, C4H), 4.12-4.08 (m 1H, C2H), 3.92-3.77 (m 
3H, C6,5H), Literature 1H NMR (CDCl3, 400 MHz) δ 7.25–7.16 (m, 15H), 6.35 (dd 1H, J = 
6.1, 1.1 Hz), 4.80 (dd, J = 6.2, 2.7 Hz, 1H), 4.76 (d, J = 11.3 Hz, 1H), 4.56 (d 1H, J = 11.3 Hz), 
4.55 (d 1H, J = 11.8 Hz), 4.54 – 4.45 (m, 3H), 4.16 – 4.12 (m, 1H), 3.99 (ddd 1H, J = 8.2, 5.0, 
2.9 Hz), 3.79 (dd 1H, J = 8.7, 6.2 Hz), 3.74 (dd 1H, J = 10.7, 5.0 Hz), 3.69 (dd 1H, J = 10.7, 
2.9 Hz) (109). 13C NMR (CDCl3, 100 MHz) δ 144.9, 138.4, 138.3, 138.1, 127.9, 127.9, 127.8, 
100.1, 76.9, 75.8, 74.9, 73.6, 70.7, 68.6. max: 3400, 3087, 3064, 3028, 2896, 2859, 1968, 1722, 
1650, 1600, 1586, 1495, 1452, 1366, 1245, 1120, 1098, 1043, 1006, 970 cm-1. 
 
3,4,6-tri-O-benzyl D-glucopyranose 142 
 
Benzyl ether 141 (11.62 g 0.0279 mol) was dissolved in 100 mL of acetone at r.t. NMO (3.68 
g, 0.0314 mol, 1.126 eqv.), water (50 mL) and OsO4 (1.56 mL, 10 mg/100 mL t-butyl alcohol) 
were added and the reaction was stirred for 16 h at room temperature. The reaction was washed 
with water (100 mL), and extracted with EtOAc (3 × 100 mL). The combined organic phases 
were then washed with water (2 x 100 mL) and brine (100 mL). The Aqueous phase was 
disposed of as heavy metal waste. The organic phase was then dried over MgSO4 and 
concentrated. The resulting off white oil was purified via silica gel chromatography using a 
20−100% EtOAc in hexanes gradient to afford diol 142 as a colourless glass (9.15 g 72.88%). 
1H NMR (CDCl3, 400 MHz) δ 7.43-7-16 (m 15H, Ar), 5.26 (d 1H, J = 6.96 Hz, C1H), 5.00-
4.94 (m 1H, C3H), 4.90-4.55 (m 6H, Bn), 4.09 (dt 1H J = 12.4, 4 Hz, C2H), 3.87 (dd 1H J = 
12.32, 3.2 Hz, C4H), 3.73-3.53 (m 3H, C5,6H), 2.94 (br s 1H, OH) 2.25 (br s 1H, OH), 
Literature 1H NMR (CDCl3, 200 MHz) δ 7.39-7.16 (m, 15 H), 5.27 (t, J = 3.4 Hz,), 4.85 (m), 
4.55-4.47 (m), 4.06 (dt, J = 3.4, 9.7 Hz), 3.81 (t, J = 9.0 Hz), 3.35 (d, J = 3.2 Hz), 2.43 (br s), 
2.22 (d, J = 3.4 Hz), 1.61 (br s) (110). 13C NMR (CDCl3, 100 MHz) δ 138, 128.7, 128, 101.8, 
75.3, 74.1, 73.5, 72.2, 71.2, 69.2, 68.5, 67.7. max: 3458 (Broad), 2927, 2869, 1765, 1496, 
1453, 1366, 1234, 1044, 1027, 910 cm-1. m/z Theoretical 468.2381 ([M+NH4]+), observed 
468.2371 ([M+NH4]+). Specific Rotation [α]D20 -0.18 (0.6 mg/mL in EtOH). 
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1,2-di-O-acyl 3,4,6-tri-O-benzyl D-glucopyranoside 143 
 
Diol 142 (10.38 g, 0.023 mmol) was mixed with acetic anhydride (100 mL) at r.t. H2SO4 (1 
drop, <0.1 mmol) was added, and the reaction was stirred for 16 h. The reaction was then diluted 
with EtOAc (200 mL) and quenched with saturated NaHCO3 (200 mL) and extracted twice with 
EtOAc (2 × 200 mL). The combine organic phases were washed twice with water (2 x 200 mL) 
and once with brine (200 mL). The organic phase was dried with MgSO4 and concentrated to 
afford a crude yellow oil. The residue was purified via silica gel chromatography using a 10% 
– 100% EtOAc in hexanes gradient to afford acetate 143 as a colourless glass (9.4 g 80.1%). 
1H NMR (CDCl3, 400 MHz) δ ppm 7.38-7.19 (m 15H, Ar), 6.24 (d 0.55H, J = 3.54 Hz, C1H 
(α)), 5.61 (d 0.45H, J = 8.23 Hz, C1H (β)), 5.06-5.01 (m 1H, C3H), 4.87-4.74 (m 6H, Bn), 4.64-
4.45 (m 2H, C2,4H), 3.98-3.62 (m 3H, C5,6H), 2.12 (s 1.65H, Ac(α)), 2.04 (s 1.35H, Ac (β)) 
1.97 (s 3H, Ac), Literature 1H NMR (CDCl3, 100 MHz): δ 7.28–7.07 (m, 15H), 6.28 (d, 1H, J 
= 10 Hz), 5.13 (dd, 1H, J = 9.2 Hz, 9.6 Hz), 4.89–4.63 (m, 5H), 4.50 (m, 2H), 3.75 (m, 4H), 
3.57 (m, 1H), 1.99 (s, 3H), 1.97 (s, 3H) (111). 13C NMR (CDCl3, 100 MHz) δ 170, 169.6, 169.3, 
138.1, 137.9, 137.8, 128.6, 128.6, 128.5, 128.1, 128, 128, 92.3, 90, 82.8, 80, 77.4, 75.5, 75.5, 
75.3, 75.2, 68.1, 21.9, 20.9, 20.8. max: 3063, 3032, 2872, 1748, 1497, 1454, 1360, 1234, 1213, 
1129, 1078, 1053, 1027, 911 cm-1. Specific Rotation [α]D20 -0.10 (2.8 mg/mL in EtOH). 
 
Ethane 2-O-acetyl 3,4,6-tri-O-benzyl D-thioglucopyranoside 143b 
 
Acetate 143 (2.04 g, 0.04 mol) was dissolved in 25 mL of DCM at 0oC. HSEt (0.35 mL, 4.8 
mmol, 1.2 eqv.) and SnCl4 (2 mL, 0.001 mol as a 2 molar solution in DCM) were added, the 
reaction was stirred and allowed to warm to r.t. The reaction was stirred for two days, and 
further SnCl4 (2 mL 0.001 mol as a 2molar solution in DCM) was added every 24 h. The 
reaction was quenched with 1mol HCL (25 mL), and extracted with DCM (3 × 25 mL). The 
combined organic phases were then washed with water (2 x 25 mL) and brine (25 mL). It was 
then dried over MgSO4 and concentrated. The resulting yellow oil was purified via silica gel 
chromatography using a 20−100% EtOAc in hexanes gradient to afford Ethane 2-O-acetyl 
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3,4,6-tri-O-benzyl D-thioglucopyranoside 143b as a colourless clear glass (1.47 g, 68.4%, α:β 
2:3). 1H NMR (CDCl3, 400 MHz) δ 7.35-7.24 (m 15H, Ar), 5.58 (d 1H J = 5.52 Hz, C1H), 
5.04-4.97 (m, 1H, C3H), 4.85-4.69 (m 3H, Bn), 4.56 (dd, 1H, J = 11, 4 Hz, C2H), 4.38-4.09 (m 
4H, Bn), 4.26 (dt, 1H J = 8.4, 2.8 Hz, C4H), 3.72-3.54 (m 3H, C5,6H), 2.74-2.60 (m 0.8H (α), 
SEt CH2), 2.60-2.45 (m 1.2H (β), SEt CH2), 2.01 (s 3H, Ac), 1.23 (t 3H, J = 15.12 Hz, SEt 
CH3). Literature 
1H NMR (CDCl3): δ 7.26–7.41 (m, 15H, Ar-H) 5.10 (t, 1H, J = 9.2 Hz, H-2), 
4.88 (d, 1H, J = 11.3 Hz, CH2Ph), 4.86 (d, 1H, J = 10.6 Hz, CH2Ph), 4.76 (d, 1H, J = 11.4 Hz, 
CH2Ph), 4.68 (d, 1H, J = 12.1 Hz, CH2Ph), 4.64 (d, 1H, J = 11.0 Hz, CH2Ph), 4.62 (d, 1H, J 
= 12.2 Hz, CH2Ph), 4.43 (d, 1H, J = 10.0 Hz, H-1), 3.83 (dd, 1H, J = 11.1, 1.9 Hz, H-6b), 3.78 
(dd, 1H, J = 11.3, 4.5 Hz, H-6a), 3.77 (t, 1H, J = 8.8 Hz, H-4), 3.74 (t, 1H, J = 9.0 Hz, H-3), 
3.57 (m, 1H, H-5), 2.78 (m, 2H, SCH2CH3), 2.05 (s, 3H, CH3CO), 1.33 (t, 3H, J = 7.4 Hz, 
SCH2CH3), (112). 13C NMR (CDCl3, 100 MHz) δ ppm 170.8, 137.7, 14.9, 128.6, 127.9, 127.7, 
84.6, 82, 80.9, 75.6, 75.2, 73.5, 69.1, 63, 24.3, 21. max: 2964, 2346, 2021, 1743, 1364, 1228, 
1099, 1037 cm-1. Specific Rotation [α]D20 -0.10 (5.6 mg/mL in EtOH). 
 
Ethane 3,4,6-tri-O-benzyl D-thioglucopyranoside 144 
 
Ethane 2-O-acetyl 3,4,6-tri-O-benzyl thioglucoside (3.3 g, 0.00615 mol) was dissolved in 300 
mL of Methanol at 0 oC. NaOMe (3 mL, 25% w.t. solution in Methanol) was added and the 
reaction was stirred and allowed to warm to r.t. The reaction was stirred for 16 h. The reaction 
was quenched with ion exchange resin amberlite ir-120(h). The organic phase was then 
concentrated and dried under high vacuum. The resulting off white solid alcohol 144 was 
recrystallized to a white powder from Hexane (3 g, 98.4%, α:β 2:3). M.p. 88 – 89 oC. 1H NMR 
(400 MHz, CHLOROFORM-d) δ ppm 7.40-7.22 (m, 15H, Ar), 5.35 (d, J = 5.49 Hz, 1H, C1H), 
4.97-4.58 (m, 6H, Bn), 4.35 (d 1H, J = 9.61 Hz, C3H), 4.34-4.31 (m, 1H, C2H), 4.21-4.09 (m 
1H, C4H) 3.72-3.47 (m, 3H, C5,6H), 2.71-2.67 (m 0.8H, (α)SEt CH2), 2.68-2.57 (m, 1.2H, 
(β)SEt CH2), 1.38-1.23 (m, 3H, SEt CH3), Literature lH NMR (CDC13): δ 7.1-7.4 (m, 15H, 
Ar’s), 4.8-5.0 (m, 3H. Bn’s), 4.5-4.6 (m, 3H, Bn’s), 4.3 (d, 1H. J = 9 Hz, H-l), 3.4-3.8 (m. 6H, 
H-2-H-6b). 2.70 (2 dq, 2H. CH2S). 1.30 (t. 3H. J = 7.0 Hz, Me) (113). 13C NMR (100 MHz, 
CHLOROFORM-d) δ ppm 138.5, 138.1, 128.6, 128.1, 128, 86.5, 84.5, 79.7, 77.7, 74.8, 73.5, 
3. Experimental   
 135 
72.1, 61.8, 24.7, 15.3. max: 3273, 2921, 2883, 1454, 1971, 1354, 1151, 1072, 1057, 1015, 960 
cm-1. Specific Rotation [α]D20 +1.29 (3.6 mg/mL in EtOH). 
 
4-penten-1-yl (2-O-acetyl) (3,4,6-tri-O-benzyl) D-glucopyranoside 97 
 
Acetate 143 (1.67 g, 0.00312 mol) was dissolved in 25 mL of DCM at 0 oC. 4-penten-1-ol 
(0.32 mL, 1.2 eqv.) and SnCl4 (2 mL, 0.001 mol as a 2m solution in DCM) were added, the 
reaction was stirred and allowed to warm to r.t. The reaction was stirred for 3 days, and SnCl4 
(2 mL 0.001 mol as a 2 N solution in DCM) was added every 24 h. The reaction was 
quenched with 1mol HCL (25 mL), and extracted with DCM (3 × 25 mL). The combined 
organic phases were then washed with water (2 x 25 mL) and brine (25 mL). It was then dried 
over MgSO4 and concentrated. The resulting yellow oil was purified via silica gel 
chromatography using a 20−100% EtOAc in hexanes gradient to afford n-pentenyl glycoside 
146 as a colourless clear glass (1.3 g, 74.3%). 1H NMR (CDCl3, 400 MHz) δ ppm 7.39-7.15 
(m, 15H, Ar), 5.86-5.75 (m, 1H, Vinyl CH), 5.08-4.94 (m, 3H, C1H, Vinyl CH2), 4.84-4.50 
(m, 6H, Bn), 4.36 (d 1H, J = 7.89 Hz, C3H), 3.93-3.85 (m, 1H, C2H), 3.80-3.64 (m, 4H 
C4,5,6H), 3.54-3.39 (m, 2H, Pent CH2), 2.17-2.06 (m, 2H, Pent CH2), 1.98 (s, 3H, Ac), 1.68 
(dd 2H, J = 13.40, 6.62 Hz Pent CH2). 
13C NMR (CDCl3, 100 MHz) δ 172.9, 137, 131.87, 
131.8, 131.3, 119, 104.5, 86.1, 80.7, 79.1, 78.8, 78.5, 78.3, 77, 71.4, 71.1, 33.1, 32.1, 24.2. 
max: 3490, 3030, 2924, 1749, 1729, 1497, 1453, 1366, 1315, 1215, 1051, 1027, 911 cm-1. 
Specific Rotation [α]D20 +0.34 (1.5 mg/mL in EtOH). 
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4-penten-1-yl 3,4,6-tri-O-benzyl-D-glucopyranoside 147 
 
n-pentenyl glycoside 146 (1.3, 2.318x10-3 mol) was dissolved in 300 mL of Methanol at 0 oC. 
NaOMe (3 mL, 25% w.t. solution in Methanol) was added and the reaction was stirred and 
allowed to warm to r.t. The reaction was stirred for 16 h. The reaction mixture was 
concentrated under vacuo. The off-white syrup was diluted with ethyl acetate and transferred 
into a separating funnel where it was washed with water. The aqueous phase was extracted 
with 2x100 mL of ethyl acetate. The Combined organic phase was washed with 2x100 mL of 
water and 100 mL of brine, it was then dried over magnesium sulphate and concentrated under 
high vacuum. The resulting off white solid, alcohol 147, was recrystallized to a white 
crystalline solid from 20% dichloromethane in Hexane (1.168 g, 97.2%). 1H NMR (CDCl3, 
400 MHz) δ ppm 7.41-7.25 (m, 15H, Ar), 5.84 (ddt 1H, J = 17.02, 10.28, 6.65, 6.65 Hz, Vinyl 
CH), 5.09-4.94 (m, 3 H, C1H, Vinyl CH2), 4.88-4.82 (m 1H, C3H), 4.69-4.53 (m, 6H, Bn), 
4.26 (d 1H, J=7.32 Hz, C2H), 3.96 (dt 1H, J = 9.58, 6.53 Hz, C4H), 3.81-3.67 (m, 3H, C6H, 
Pent CH2), 3.65-3.48 (m, 2H, C5,6H), 2.45 (br s, 1H, OH), 2.20-2.13 (m, 2H, Pent CH2), 1.84-
1.69 (m, 2H, Pent CH2). M.p. 61-62
oC, m/z Theoretical 517.259 (M-H), observed 517.2594 
(M-H), Theoretical 536.2992 ([M+NH4]+), observed 536.3007 ([M+NH4]+). Specific 
rotation [α]D20 +0.15 (1.7 mg/mL in EtOH). max: 3088, 3062, 3029, 2905, 2867, 1497, 1453, 
1358, 1207, 1130, 1064, 1026, 1000, 912 cm-1.  
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Crystal cell (single anomer purified from column chromatography): a = 5.2868(2), b = 
18.3054(5), c = 29.7257(8), α = 90, β = 90, γ = 90, Space group P 21 21 21,  
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4-penten-1-yl 2-O-p-methoxybenzyl-3,4,6-tri-O-benzyl-D-glucopyranoside 
174 
 
 
n-pentenyl glycoside 147 (0.94 g, 0.00181 mol) was dissolved in 5 mL of DMF at 0 oC. p-
Methoxy benzylchloride (0.35 mL, 1.2 eqv.) and tetra-n-Butyl Ammonium Iodide (0.1 g) were 
added and dissolved. Neat NaH (0.05 g 1.2 eqv) was added. The reaction was stirred for 16 h 
at 0 oC and allowed to warm to room temperature. The reaction was quenched with water (15 
mL), and extracted with Et2O (3 × 20 mL). The combined organic phases were then washed 
with water (2 x 20 mL) and brine (20 mL). It was then dried over MgSO4 and concentrated. 
The resulting yellow oil was purified with silica gel chromatography using a 12% EtOAc in 
hexanes to afford p-methoxy benzyl ether 174 as a white solid (0.996 g, 86.2%). 1H NMR 
(CDCl3, 400 MHz) δ ppm 7.41-7.25 (m 15H, Bn), 7.22-7.15 (m 2H, p-Bn), 6.94-6.85 (m 2H, p-
Bn), 5.88 (ddt 1H, J = 17.02, 10.31, 6.63, 6.63 Hz, Vinyl CH), 5.11-4.90 (m 4H, C1,3H, Vinyl 
CH2), 4.90-4.49 (m 8H, Bn CH2), 4.42 (dd 1H, J = 7.78 Hz, C2H), 4.05-3.98 (m 1H, C4H), 
3.83-3.80 (m 3H, OMe), 3.80-3.71 (m 2 H, C5,6H), 3.71-3.42 (m 3H, C6H, Pent CH2), 2.27-
2.13 (m 2H, Pent CH2), 1.87-1.74 (m 2H, Pent CH2). M.p. 67 – 68. Specific rotation [α]D20 
+0.03 (1.1 mg/mL in EtOH). max: 3062, 2933, 2861, 1586, 1514, 1451, 1367, 1302, 1251, 
1172, 1117, 1059, 1036, 949 cm-1. 
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4-penten-1-yl 2-O-(2-methyl) naphthyl-3,4,6-tri-O-benzyl-D-
glucopyranoside 175 
 
n-pentenyl glycoside 147 (1.03 g, 0.00199 mol) was dissolved in 5 mL of DMF at 0 oC. 2-
(bromomethyl) naphthalene (0.52g, 1.2 eqv.) and tetra-n-Butyl Ammonium Iodide (0.1g) were 
added and dissolved. Neat NaH (0.06g, 1.2 eqv) was added. The reaction was stirred for 16h 
at 0oc and allowed to warm to room temperature. The reaction was quenched with water (15 
mL), and extracted with Et2O (3 × 20 mL). The combined organic phases were then washed 
with water (2 x 20 mL) and brine (20 mL). It was then dried over MgSO4 and concentrated. 
The resulting yellow oil was purified with silica gel chromatography using a 12% EtOAc in 
hexanes to afford (2-methyl) naphthyl ether 175 as an off white solid (0.84 g, 64.2%). 1H 
NMR (CDCl3, 400 MHz) δ 7.87-7.73 (m, 5H). 7.51-7.41 (m 4H), 7.37-7.23 (m 13H), 5.83 
(ddt 1H, J=17.05, 10.26, 6.56, 6.56 Hz, CH Vinyl), 5.11-4.74 (m 7H, C1,3,2H and Bn(4Hs)) 
4.62-4.49 (m 3H, C4H Vinyl CH2), 4.45-4.4 (m 1H, C6H), 4.04-3.95 (m 1H, C5H), 3.79-3.42 
(m 7H, C6H, Bn(4Hs), Pent CH2), 2.23-2.14 (m 2H, Pent CH2), 1.83-1.72 (m 2H, Pent CH2), 
m/z Theoretical 658.3295 (M), observed 658.3287 (M), Theoretical 676.3633 ([M+NH4]+), 
observed 676.3621 ([M+NH4]+). max: 3057, 2927, 2871, 2176, 2022, 1719, 1451, 1369, 
1354, 1275, 1118, 1058, 1037, 1028, 964 cm-1. Specific rotation [α]D20 +0.14 (0.7 mg/mL in 
EtOH). 
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1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose 148 
 
Galactose (10 g) was stirred in acetone (100 mL) with a catalytic amount of camphorsulphonic 
acid. 2,2-dimethoxypropane (2.1 eqv.) was added into the mixture gradually over a minute. 
The mixture was then brought to reflux, and stirred until dissolution occurred. Once 
dissolution had occurred the reaction was then allowed to cool to room temperature. The 
solution was then concentrated under vacuo and the crude syrup was dissolved in 100 mL 
ethyl acetate. The was then transferred to a separating funnel where it was washed with 100 
mL of water. The aqueous phase was then extracted with a further 2x100 mL of ethyl acetate. 
The combined organic phases where washed with a further 2x100 mL of water and 100 mL of 
brine. The ethyl acetate was then dried over magnesium sulphate and concentrated to an off-
white syrup. The crude syrup was then purified with flash column chromatography (20% 
EtOAc – Hexane to neat EtOAc) to yield 148 as a pure colourless oil. Specific rotation [α]D20 
-0.84 (3.3 mg/mL in EtOH). max: 3411 (broad), 2986, 2938, 2894, 2034, 1653, 1520, 1381, 
1210, 1166, 1096, 1067, 1000, 918, 899 cm-1. 
 
1,2:3,4-Di-O-isopropylidene-6-(2-methyl) naphthyl-α-D-galactopyranose 
177 
 
Alcohol 148 (3.145 g, 0.012 mol) was dissolved in 50ml of DMF at 0 oC. 2-(bromomethyl) 
naphthalene (2.67 g 0.0.12 mol) and tetra-n-Butyl Ammonium Iodide (1 g) were added and 
dissolved. NaH (0.5 g as a 60% dispersion in mineral oil) was added. The reaction was stirred 
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for 16h at 0oc and allowed to warm to room temperature. The reaction was quenched with 
water (150 mL), and extracted with Et2O (3 × 200 mL). The combined organic phases were 
then washed with water (2 x 200 mL) and brine (200 mL). It was then dried over MgSO4 and 
concentrated. The resulting yellow oil was purified via basic (5% triethylamine treated) silica 
gel chromatography using a 12% EtOAc in hexanes to afford (2-methyl) naphthyl ether 177 
as a colourless oil (11.62g, 54%%). 1H NMR (CDCl3, 400 MHz) δ 7.85-7.77 (m 4H), 7.52-
7.42 (m 3H), 5.56 (d 1H, J = 5.03 Hz, C1H), 4.83-4.68 (m 2H, CH2 Naph), 4.60 (dd 1H, J = 
7.95, 2.34 Hz, C3H), 4.34-4.26 (m 2H, C24H), 4.06-4.00 (m 1H, C6H), 3.77-3.65 (m 2H, 
C5,6H), 1.56-1.51 (m 3H), 1.45-1.42 (m 3H), 1.33 (s 6H). Literature (114). max: 3237, 2985, 
2936, 2907, 2176, 2035, 2020, 1978, 1509, 1380, 1278, 1253, 1210, 1168, 1101, 1068, 1002, 
890 cm-1. Specific rotation [α]D20 -0.48 (1.4 mg/mL in EtOH). . 
 
Benzyl Ethyl Sulphide 159 
 
Ethane thiol (7 mL) was dissolved in 25ml of DMF at r.t. with benzyl bromide (7 mL) and 
dissolved. To the solution 7 mL of lutidine was added dropwise at 0 oC. A small amount of 
TBAI was add and the reaction was stirred for 4 h and allowed to warm to room temperature. 
And then overnight. The reaction was quenched with water (50 mL), and extracted with Et2O 
(3 × 50 mL). The combined organic phases were then washed with water (2 x 50 mL) and 
brine (50 mL). It was then dried over MgSO4 and concentrated to afford sulphide 159 as a 
colourless liquid (5.35g, 86%). 1H NMR (CDCl3, 400 MHz) δ 7.31-7.22 (m 5H), 3.73 (s 2H), 
2.44 (q 2H, J = 7.38, 11.04), 1.242 (t, J = 7.41, 3H), 13C NMR (CDCl3, 400 MHz) δ 138.5, 
128.9, 128.8, 128.4, 126.8, 35.5, 25.2, 14.3. m/z Theoretical 151.0582 (M-H), observed 
151.0585 (M-H). 
 
Benzyl Phenyl Sulphide 159b 
 
Phenylthiol (0.67g, 0.0061mol) was dissolved in 25 mL of DMF at r.t. with benzyl bromide 
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(1.25 g 0.00732 mol, 1.2 eqv.) and dissolved. The solution was cannulated onto NaH (0.24 g, 
0.0061 mol 60% dispersal in mineral oil.) mixed with 5 ml of DMF at 0 oC. The reaction was 
stirred for 4 h and allowed to warm to room temperature. The reaction was quenched with 
water (50 mL), and extracted with Et2O (3 × 50 mL). The combined organic phases were then 
washed with water (2 x 50 mL) and brine (50 mL). It was then dried over MgSO4 and 
concentrated to afford benzyl phenyl sulphide 159b as a colourless liquid (1.12 g, 91.7%). 1H 
NMR (CDCl3, 400 MHz) δ 7.30-7.19 (m 10H), 4.15 (s 2H), 
 
Benzyl Ethyl Sulphoxide 159c 
 
 
 
EtSBn 159 (4.96 g) was dissolved in Methanol (50 mL) stirred and cooled to 0 oC. An aqueous 
solution of KIO4 (7.5 g in 50 mL) was added dropwise from a dropping funnel over an hour 
and the reaction was allowed to warm to room temperature. The reaction was stirred for a 
further 24 h. The solution was then concentrated, diluted with water (10 mL) and transferred 
to a separating funnel, the aqueous phase was extracted with chloroform (3x50 mL). The 
combined organic phases where washed with water (2x50 mL) and brine (50 mL) and dried 
over magnesium sulphate. The solution was then concentrated under vacuum to yield the 
sulphide 159c as an off white solid. 1H NMR (CDCl3, 400 MHz) δ 7.2 – 7.3 (m, 5H), 3.88 (q, 
J1= 10.59, J2= 12.9, 2H), 2.44 – 2.60 (m, 2 H), 1.24 (t, J= 7.5, 3H). m/z Theoretical 169.0682 
(M+H), observed 169.0678 (M+H). Specific rotation [α]D20 -0.05 (1.7 mg/mL in EtOH). 
 
1-Chloro 1-Phenyl Methyl Ethyl sulphide 159d 
 
Benzyl Ethyl Sulphide 159 (0.5 mL) was dissolved in CCl4 (10 mL) under an inert N2 
atmosphere from a N2 balloon, and septum, and stirred at room temperature. NCS (0.44 g) was 
added. Once the NCS had dissolved the solution was left to stir for 16 hours. The reaction was 
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then quenched with aqueous sodium thiosulphate (10% solution) and transferred to a 
separating funnel. Where it was separated and the aqueous phase extracted into DCM (3x10 
mL). The combined organic phases were then washed with water (2x10) and brine (10 mL) 
before being dried over magnesium sulphate and concentrated under vacuum to yield an 
odorous of-white liquid. H1 NMR analysis showed mainly starting material.  
 
4-penten-1-yl 2-O-p-methoxybenzyl-(O-n-penten-1-al)-3,4,6-tri-O-benzyl-
D-glucopyranoside 172 
 
p-methoxy benzyl ether 174 (51 mg, 0.08 mmol) was dissolved in DCM (10 mL) with 4Å-
molecular sieves and under an inert, dry, N2 atmosphere from a schlenk line, and stirred at room 
temperature. N-Penten-1-ol (7 mg) was injected, and the solution was cooled to 0 oC. DDQ 
(230 mg) was added and the solution was left to stir for 8 hours. The reaction was then quenched 
with aqueous sodium hydrogen carbonate (20 ml, 20% solution) and transferred to a separating 
funnel. The DCM was separated and the aqueous phase extracted into DCM (1x10 mL). The 
combined organic phases were then dried over magnesium sulphate and concentrated under 
vacuum to yield an odorous of-white liquid. The residue was then purified by basic aluminium 
column chromatography with DCM – Hexane (25%). H1 NMR analysis showed some of the 
mixed acetal 172, but mainly alcohol 147 and p-methoxy benzaldehyde. 
 
4-penten-1-yl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 17 
 
2,3,4,6-tetra-O-benzyl glucopyranoside (1.01 g, 0.00187mol) was dissolved in 25 mL of DMF 
at r.t. with 5-bromopent-1-ene (0.33 mL 0.0028mol, 1.5eqv.) and dissolved and cooled to -84 
oC. The solution was cannulated onto NaH (0.0822 g, 0.002 mol, 1.1 eqv. 60% dispersal in 
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mineral oil.) mixed with 5ml of DMF also cooled to -84 oC. The reaction was stirred for 16 h 
and allowed to warm to room temperature. The reaction was quenched with water (50 mL), 
and extracted with Et2O (3 × 50 mL). The combined organic phases were then washed with 
water (2 x 50 mL) and brine (50 mL). It was then dried over MgSO4, concentrated and purified 
under flash column chromatography (Hexanes:EtOAc 4:1) afford glycoside 17 as a colourless 
oil (0.863g, 75.8%). 1H NMR (CDCl3, 400 MHz): 
 
 Literature 1H NMR (500 MHz, CDCl3) mixture of anomers (α/β = 1.2:1) δ 7.40-7.21 (m, 
22H), 7.15 (ddd 3H, J = 11.3, 7.3, 2.0 Hz), 5.81 (ddd 1H, J = 17.0, 10.3, 8.3 Hz), 5.03 (dd 1H, 
J = 3.6, 1.8 Hz), 5.02-4.89 (m, 4H), 4.85-4.69 (m, 5H), 4.67-4.50 (m, 3H), 4.47 (dd 1H, J = 
11.4, 3.4 Hz), 4.38 (d 1H, J = 7.7 Hz), 4.03-3.91 (m, 2H), 3.81-3.69 (m, 2H), 3.69-3.59 (m, 
4H), 3.58-3.50 (m, 2H), 3.48-3.39 (m, 2H), 2.22-2.07 (m, 3H), 1.81-1.69 (m, 3H) (115). max: 
3063, 3031, 2916, 2875, 2865, 1964, 1640, 1496, 1471, 1451, 1403, 1369, 1356, 1316, 1278, 
1199, 1118, 1058, 1039, 998, 949, 913 cm-1. Specific rotation [α]D20 -0.03 (0.6 mg/mL in 
EtOH). 
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α-Methyl 2,3,4-tri-O-benzyl-D-glucopyranoside 18 
 
1H NMR (CDCl3, 400 MHz) δ 7.56-7.48 (m, 3H, Ar), 7.44-7.30 (m, 12H, Ar), 5.61-5.55 (m, 
1H, C1H), 4.98-4.83 (m, 3H, Bn), 4.77-4.58 (m, 3H, Bn), 4.33-4.24 (m, 1H, C5H), 4.13-4.03 
(m, 1H, C2H), 3.91-3.81 (m, 1H, C3H), 3.78-3.69 (m, 1H, C4H), 3.67-3.55 (m, 2H, C6H2), 
3.41 (s, 3H), Literature 1H NMR (400 MHz, CDCl3): δ 7.34-7.29 (m, 15H, Ar-H), 5.00-4.62 
(m, 6H, PhCH2O-), 4.56 (d 1H, J = 3.5Hz, 1-H), 4.02-3.48 (m, 7H), 3.36 (s 3H, OCH3) (116). 
max: 3482, 3032, 2699, 2948, 2928, 2902, 2871, 1727, 1497, 1452, 1361, 1347, 1208, 1187, 
1160, 1141, 1085, 1068, 1056, 1026, 1017, 993, 970, 912 cm-1, Specific rotation [α]D20 -0.30 
(3.7 mg/mL in EtOH). 
 
Methyl O-(2,3,4,6-tetra-O-benzyl-D-glucopyranosyl) -(1→6)-2,3,4-tri-O-
benzyl-α-D-glucopyranoside 19 
 
Glucoside 17 (0.449 g, 0.000738mol) and glucoside 18 (0.312g, 0.00067mol) where mixed 
together with a stirrer bar and activated 4Å molecular sieves (1g) under high vacuum for an 
hour. The mixture was then flushed with nitrogen and to which was added stock dry DCM (5 
mL). The mixture was cooled to 0oc and NIS (0.332g, 0.00147mol) was added. The reaction 
was stirred at 0 oC until the reaction mixture had turned pink-purple. It was then allowed to 
warm to r.t. and stirred for a further 16 h. The reaction was then quenched with aqueous 
sodium thiosulphate (10% solution) and transferred to a separating funnel. Where it was 
separated and the aqueous phase extracted into DCM (3x10 mL). The combined organic 
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phases were then washed with water (2x10 mL) and brine (10 mL) before being dried over 
magnesium sulphate and concentrated under vacuum to yield the crude colourless oil, which 
was purified under flash column chromatography (EtOAc – hexanes 10%) to yield the 
disaccharide 19, as a mixture of anomers, as a colourless oil (0.450g, 68%) (α:β 2:1 by 1H 
NMR). 13C NMR (CDCl3, 100 MHz) δ 135.8, 125.3, 125, 124.6, 94.9, 94.2, 77.1, 77.1, 74, 
73.7, 72.7, 71.9, 70.4, 67.3, 67.2, 65.5, 65.4, 52.1. max: 3108, 3088, 3063, 3029, 2905, 2862, 
1497, 1453, 1358, 1207, 1186, 1160, 1131, 1099, 1064, 1026, 1001, 912, 732, 694 cm-1. 
Specific rotation [α]D20 -0.08 (1.5 mg/mL in EtOH).  
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 Our 1H NMR: 
 
 Literature 1H NMR (14): 
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